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ABSTRACT
In the neuron, membrane fusion is the fundamental process in which neurotransmitters are
released to the synapse. It is believed that the SNARE complex is the minimal fusion machinery
that drives synaptic membrane fusion. This is a multi-step process that is regulated by a host of
accessory proteins, however it is unclear how they affect the distinct stages of membrane fusion. In
this work, we have identified regions on the SNARE complex that are integral for progression to
vesicle fusion, while also investigating the function of the presynaptic protein, α-synuclein. Through
investigation of Botulinum toxin A/E cleavage products, we have found that truncation of the C-
terminal of SNAP-25 causes dynamic destabilization leading to impaired SNARE complex assembly
resulting in loss of vesicle docking and pore formation. In addition, we have found that monomeric
α-synuclein continues to enhance vesicle docking at overexpressed conditions. The removal of the
higher ordered oligomers eliminated any inhibition of lipid merger. Furthermore, α-synuclein was
shown to directly stimulate fusion pore expansion by stabilizing the large pore state through its
membrane binding ability. Thus, α-synuclein biases the membrane fusion pathway towards full
exocytosis in vesicle recycling. Altogether, the work presented here suggests a model where the
SNARE complex, assisted by α-synuclein, is capable of progression through several intermediate




The height of human cognition is a biological marvel made possible by highly regulated neuronal
communication. This process relies on a neuron generating an action potential in response to an
external stimuli. The action potential causes depolarization of the membrane allowing it to travel
down the axon to the synapse of the neuron1. As this action potential reaches the synapse, it triggers
a series of voltage-gated ion channels that allow a rapid influx of Ca
2+
. This influx causes docked and
primed vesicles encapsulating neurotransmitters to synchronously fuse to the plasma membrane.
During membrane fusion, vesicles form a fusion pore that allows internal neurotransmitters to be
released into the synaptic space. The neurotransmitters are received by receptors on the post-
synaptic terminal, thus propagating the signal2,3.
It is now widely accepted that the highly-conserved soluble N-ethylmaleimide sensitive fac-
tor attachment protein receptor (SNARE) complex is the core machinery for synaptic membrane
fusion4,5. The critical role that SNAREs play in neuronal communication have made them a pop-
ular subject of study, however there are many aspects about their role in membrane fusion that
are still poorly understood. One in particular is elucidating the discrete stages in the membrane
fusion pathway and defining how accessory proteins are involved in the complex regulation of these
stages6. Moreover, there is mounting evidence showing that even though SNAREs are capable of
membrane fusion, they are highly inefficient alone7,8. Defective regulation of neuronal communi-
cation has been implicated as the one of the main causes of neurodegenerative diseases9,10. Thus,
further investigation of the regulation of SNARE-mediated fusion pathway would shed more light
on the details on treatments and prevention of neurodegenerative diseases.
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1.2 SNARE-mediated vesicle fusion
The SNARE complex is comprised of three individual proteins: syntaxin 1A, synaptosomal
nerve-associated protein 25 (SNAP-25) and VAMP211,12. Syntaxin 1A is attached to the plasma
membrane through a C-terminal transmembrane domain, while SNAP-25 is a soluble protein bound
to the plasma membrane by palmitoylation. These two t-SNAREs proteins come together to form
a binary t-SNARE complex prior to membrane fusion13–15. The v-SNARE is composed of VAMP2
which is affixed to the vesicle via a C-terminal transmembrane domain. To perform membrane
fusion, v- and t-SNAREs assemble and form the SNARE complex through interaction of their
SNARE motifs.
Individually the SNARE motifs are unstructured, but when in close proximity they form a
highly stable coiled coil structure11,12,16,17. VAMP2 and syntaxin 1A contain one SNARE motif,
while SNAP-25 has two SNARE motifs separated by the central linker region. The assembly of the
SNARE complex is believed provide the energy to overcome the energetically unfavorable fusion
between two membranes15,18–20. This large amount of energy is derived from a ∼60 amino acid
stretch in the SNARE motif that forms a heptad repeat21. The heptad repeat orients hydrophobic
residues on the interior of the coiled coil, while placing the hydrophilic residues on the exterior.
The SNARE complex total of 16 stacked layers of heptad repeat residues (N- and C-terminal ends
are numbered -7 and +8, respectively) with the middle of the coiled coil (zero layer) containing
an ionic interaction between one arginine and three glutamine residues. As the SNAREs assemble,
the vesicle transits through the membrane fusion pathway.
1.3 Membrane fusion pathway
To reach complete fusion, the vesicle progresses through multiple stages in the membrane fusion
pathway. The first step in the pathway is where the individual SNARE motifs zipper together origi-
nating at the membrane-distal region and progressing towards the membrane-proximal region22–24.
As the SNAREs zipper, the opposing membranes of the vesicle and the plasma membrane are
drawn closer together. Once sufficiently close, the outer leaflets of the membranes merge together
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while the interior leaflets are unchanged forming the hemifusion state25. Further zippering merges
the inner leaflets of the membranes, which forms a small aqueous fusion pore where small neuro-
transmitters are able to be released from the vesicle to the post-synaptic space. Finally, the fusion
pore continues to dilate and expands resulting in a complete merger of the two membranes15,26,27.
Pore expansion is predicted to be an extremely energy intensive process and it is unclear whether
formation of the SNARE complex alone is sufficient to drive full membrane fusion28,29. Alter-
natively, there is evidence of another mechanism termed kiss-and-run30,31. In this mechanism,
neurotransmitters are released through the small fusion pore, but the pore collapses prior to full
membrane fusion. After the pore collapses, the vesicle disengages from the plasma membrane. It is
unknown what protein factors control the bias between these two pathways. Further investigation
into the role of SNARE accessory proteins would elucidate the regulation of membrane fusion.
1.4 SNARE accessory proteins
SNAREs alone have the ability to drive membrane fusion, but for tight synchronous signaling
this process needs to be regulated by a multitude of accessory proteins. Many studies have been
devoted to identifying and characterizing the mechanism on how these proteins regulate the fusion
process.
1.4.1 α-synuclein
α-synuclein (αS) is a soluble, 14 kDa protein abundantly prevalent µM in the neuron, particu-
larly in the synapse. It is intrinsically disordered when in an aqueous solution, but has the ability
to bind to negatively charged curved membranes and form an α-helical structure32–34. It is largely
known for its pathological misfolding and aggregation into insoluble neuronal plaques and Lewy
bodies that have been shown to be linked to neurodegenerative diseases such as Parkinson’s disease
and Lewy body dementia, respectively35–37. While the aggregation of α-synuclein has been well
studied, the non-pathological function of α-synuclein has proven more elusive.
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While the function is not fully understood, studies suggest that αS may be involved in regulating
membrane fusion. Recently, there has been evidence that αS controls the size of the vesicle pool38,
vesicle clustering39, as well as vesicle docking to the plasma membrane40. In addition, αS may
stabilize SNARE complexes by interacting with VAMP241,42. Observation of αS in an in vitro
environment would further clarify the role on individual steps of membrane fusion.
1.4.2 Synaptotagmin-1
Synaptotagmin-1 (Syt1) is a 47 kDa SNARE accessory protein bound to the synaptic vesicle
via a N-terminal transmembrane domain. Syt1 contains a long cytosolic domain ended by two
C2 (C2A and C2B) domains separated by a small linker region43–45. The C2 domains can bind
5 Ca2+ ions in total, three by C2A and two by C2B, suggesting it plays a role in synchronous
membrane fusion. This notion was further reinforced by the capacity of Syt1 to bind to individual
SNARE components46. Knockout studies of Syt1 have revealed a lack of Ca2+sensitivity, strongly
implicating it as a Ca2+-sensor in synchronous membrane fusion47. Convincingly, additional studies
involving point mutations on Syt1 reveal altered Ca2+ binding affinities and sensitivities, thus
confirming Syt1 as the main Ca2+-sensor48.
Currently the main focus of Syt1 research is on identifying the mechanism behind regulation
of synchronous membrane fusion. Recent in vitro experiments involving Ca2+-bound Syt1 have
been shown to markedly increase both hemifusion and the release of vesicle content49,50. Surpris-
ingly, in the absence of Ca2+, Syt1 has been shown to inhibit spontaneous fusion implying dual
functionality51. These findings raise the question of which steps of membrane fusion Syt1 is involved
in and how it is involved.
1.5 In vitro techniques for studying SNAREs
In vitro techniques have been essential to investigate the mechanisms of SNARE-mediated
membrane fusion by individually investigating the role of each accessory protein. By using a
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combination of structural and functional techniques, a cohesive understanding of the role of each
protein can be illuminated.
1.5.1 Site-directed spin labeling (SDSL) and electron paramagnetic resonance (EPR)
The combination of SDSL and EPR have been well established methods for studying protein-
protein interaction, secondary structure, and dynamics52. This method is particularly advantageous
with investigations into large protein complexes and/or membrane reconstituted proteins. In this
technique, specific residues of interest are mutated to unique cysteines which are then attached
with a nitroxide spin label through a disulfide linkage53. The mobility of the nitroxide spin label is
sensitive to the local environment of the residue (structure, interactions, viscosity) which affects the
sharpness of its observed EPR lineshape. Analysis of the changes in EPR lineshape over different
conditions provides information on the conformational changes the protein experiences due to its
environment.
In the case of SNAREs, EPR has been critical in understanding the conformational changes
undergone in SNARE complex assembly. This method has been used in three different approaches
in order to understand SNARE complex structure and function. First, the distance between two
nitroxides can be measured by using spin labels attached at two different sites. This approach has
been used to determine the first four-helix bundle structure of the SNARE complex and t-SNARE
complex (1:1 combination of syntaxin 1A and SNAP-25)11,54. Second, the spin label is sensitive to
local environmental changes especially when moving from an aqueous to membrane environment55.
In order to achieve membrane fusion, the SNARE complex transfers energy from its soluble do-
mains to its transmembrane domains to drive lipid merger and pore expansion. This approach
was used to measure membrane immersion depth of a residue, thus identifying the zippering mech-
anism responsible for driving membrane fusion56–58. Third, a spin label changes the broadness
of the lineshape due to conformational changes protein structure59.This approach has been used
to quantify the changes SNAREs undergo when transitioning from an unstructured protein to an
α-helical coiled coil60.
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1.5.2 Single molecule total internal reflection fluorescence microscopy (smTIRFM)
While bulk fluorescence assays are still widely popular due to their ease of access and ability to
rapidly accumulate data, their main limitation is their low resolution. To counter this limitation,
researchers have turned to single molecule assays, such as smTIRFM, to study of biomolecular
mechanisms61. Opposed to standard fluorescence imaging, smTIRFM focuses the excitation of
fluorescence molecules to a precise focal plane, thus limiting the out-of-fluorescence background and
reducing photobleaching62. This high-resolution technique is permits direct visualization of binding
events and quantification of kinetics are especially useful in studying protein-protein interactions.
To employ smTIRF, incident light is transmitted through two materials with differing refractive
indices (such as a glass coverslip), followed by another with a lower refractive index (such as an
aqueous solution). The light is adjusted to a specific critical angle, so when it reaches the first
refractive material it generates an evanescent field parallel to the interface. The evanescent field
does not penetrate as deeply into the second refractive material, exponentially decaying the further
from the interface. This generates an evanscent field that selectively illuminates fluorophores close
to the surface significantly reducing the out-of-focus fluorescence. The combination of background
reduction and incident light intensity allows for single-molecule resolution over extended periods of
time.
Recently, developments in technology have made smTIRF an increasingly useful technique for in-
vestigating the function of SNAREs and accessory proteins on membrane fusion. Purified SNAREs
have been reconstituted into liposomes, generating the synthesis of v- or t-vesicles that mimic
the synaptic vesicles or plasma membrane, respectively, in an in vitro environment5. These v-
and t-vesicles serve as the basis for the development of many single-molecule assays investigating
SNAREs. One in particular is the single-molecule vesicle-vesicle assay63,64. In this assay, t-vesicles
are immobilized on an imaging surfaces while v-vesicles containing fluorescently labeled lipids or
content are introduced. This technique allows the pre- and post-fusion states of vesicles to be
investigated while observing either the lipid merger (labeled lipids) or pore formation (labeled
content).
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However, there are two main limitations of this technique. One is that the vesicle-vesicle assays
involves the fusion between two vesicles, while natural membrane fusion occurs between a vesicle
and planar synaptic surface. This difference in architecture can lead to a misrepresentation of the
steps of membrane fusion due to the steric hinderance of vesicle-vesicle fusion. Second is that this
technique is only able to capture the before and after images of fusion. This does not allow the
dynamics and kinetics of membrane fusion to be measured.
To combat these limitations, a single-molecule vesicle-to-supported bilayer assay has been
developed8,65. Instead of immobilization of t-vesicles, they are allowed to spontaneously fuse to
the imaging surface. The lipid composition of the t-vesicles contains polyethylene glycol (PEG)-PE
that creates a PEG-pillared aqueous gap between the bilayer and the quartz support through which
a fluorescent reporter could diffuse. When v-vesicle are introduced, vesicles can fuse in a situation
that more closely resembles the synaptic environment. Advances in camera technology have intro-
duced high-speed cameras capable of generating videos with 20 ms frames. These cameras are able
to record a video of SNARE-mediated fusion in real time. This technique has already been used to
dissect the details of synaptotagmin-1 involvement in SNARE-mediated lipid merger50. One could
image this technique as a platform for investigation into an array of accessory proteins to parse
their effects on the individual steps of membrane fusion.
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2.1 Abstract
Botulinum toxins (BoNT) A and E block neurotransmitter release by specifically cleaving the C-
terminal ends of SNAP-25, a plasma membrane SNARE protein. Here, we find that SNAP-25A and
E, the cleavage products of BoNT A and E respectively, terminate membrane fusion via completely
different mechanisms. Combined studies of single molecule FRET and single vesicle fusion assays
reveal that SNAP-25E is incapable of supporting SNARE pairing and thus, vesicle docking. In
contrast, SNAP-25A facilitates robust SNARE pairing and vesicle docking with somewhat reduced
SNARE zippering, which leads to severe impairment of fusion pore opening. The EPR results
show that the discrepancy between SNAP-25A and E might stem from the extent of the dynamic
destabilization of the t-SNARE core at the N-terminal half which plays a pivotal role in nucleating
SNARE complex formation. Thus, the results provide insights into the structure/dynamics-based
mechanism by which BoNT A and E impair membrane fusion.
2.2 Introduction
Synaptic communication involves neurotransmitter release from the neuron to the synaptic cleft.
The release of neurotransmitters requires synaptic vesicle docking onto the target plasma membrane,
formation of a fusion pore, and complete fusion of two membranes. It is widely believed that
this membrane fusion process is mediated by soluble N-ethylmaleimide-sensitive factor attachment
protein receptors (SNAREs). The SNARE proteins consist of VAMP2 on the synaptic vesicle (v-
SNARE) and syntaxin 1A and SNAP-25 on the target membrane (t-SNAREs). The cognate v-
and t-SNAREs, when brought into proximity, form a highly stable ternary SNARE complex that
is thought to drive fusion of two membranes1–4.
More specifically, the highly conserved SNARE motifs, one from syntaxin 1A, two from SNAP-
25 and one from VAMP2, assemble into a parallel four helix bundle5–8. It has been proposed that
SNARE complex formation is a multi-step process where zippering starts from the membrane-
distal N-terminal region and progresses towards the membrane-proximal C-terminal region8–11.
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However, the coupling mechanism between zippering steps and membrane remodeling steps has
been elusive12.
Prior to their interaction with VAMP2, syntaxin 1A and SNAP-25 form a binary 1:1 t-SNARE
complex on the plasma membrane2,13,14. It has been shown that VAMP2 has a significantly higher
affinity to the t- SNARE complex compared to the individual t-SNAREs15. Moreover, only with the
t-SNARE complex, not with individual t-SNAREs, does VAMP2 assemble into the SNARE complex
and elicit synaptic exocytosis. The importance of the t-SNARE complex may be further emphasized
with the fact that some botulinum toxins (BoNT) inhibit synaptic exocytosis by enzymatically
cleaving individual t-SNAREs16,17.
BoNTs are a class of protein toxins with eight distinct serotypes produced from clostridia. BoNT
consists of four distinct domains that function to bind to the nerve terminals, translocate into the
cytosol, and cleave SNAREs via the metalloprotease activity18. While all BoNT serotypes induce
flaccid paralysis by inhibiting neurotransmitter release at the neuromuscular junction, individual
isoforms target different SNAREs and cleave them at different positions17.
Both BoNT A and E site-specifically cleave SNAP-25 at the C-terminal SNARE motif leaving
9 and 26 residue shortened versions SNAP-25A and SNAP-25E, respectively17,19. This cleavage is
sufficient to reduce or abolish membrane fusion. While BoNT E completely abolishes neurotrans-
mitter release, BoNT A seems to have a milder effect considering some membrane fusion is rescued
with elevated levels of Ca2+ ions16,20. This may imply that BoNT E and A impair membrane
fusion at different steps. Thus, an understanding of the impact of the cleavage on the structure and
dynamics of the SNARE complexes could provide valuable insights into the mechanism by which
SNAREs mediate membrane fusion.
In order to cohesively investigate the effect of BoNT A and E cleavage on SNARE complex
formation and membrane fusion, I probed the structure and dynamics of t-SNAREs using electron
paramagnetic resonance (EPR. The results show that BoNT A and E, although otherwise similar
except that BoNT E cuts 17 residues more from SNAP-25 than BoNT A, impairs membrane
fusion through entirely different mechanisms. While SNAP-25E blocks SNARE complex formation
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and vesicle docking, SNAP-25A allows robust vesicle docking, but reduces SNARE zippering and
significantly impairs membrane fusion. The EPR results show that such big differences might stem
from the extent of the dynamic destabilization of the t-SNARE core at the N-terminal half which
plays a pivotal role in nucleating SNARE complex formation.
2.3 Results
2.3.1 Dynamic structure of the 1:1 binary t-SNARE complex of syntaxin 1A and
SNAP-25
Although the structures of the ternary SNARE complex have been thoroughly investigated in
both solution and membrane mimetics6,8,11, the t-SNARE complex is less well defined. Consid-
ering that the t-SNARE complex serves as a precursor to the ternary SNARE complex, further
insights into the structure could shed light on the mechanistic steps in the ternary SNARE complex
formation.
There are two forms of the t-SNARE complex: the non-productive 2:1 (syntaxin 1A: SNAP-
25) complex and the productive, on-pathway 1:1 complex14,21. The 2:1 t-SNARE complex has
been previously investigated with EPR21,22. The structure is a parallel four-helix bundle, basically
identical to the ternary SNARE complex, but with the second syntaxin 1A SNARE motif replacing
VAMP2. In contrast, the structure of the 1:1 t-SNARE complex has been elusive, most likely due
to the dynamic nature of the structure.
Based on their smFRET experiments in live cells, An and Almers have previously proposed
that the N-terminal SNARE motif of SNAP-25 (SN), within the 1:1 t-SNARE complex, forms a
robust helical complex with syntaxin 1A while the C-terminal SNARE motif of SNAP-25 (SC) is
detached from the complex and freely diffuses in solution23. To verify this model, we first probed
the dynamics of SN in the 1:1 complex using site-directed spin labeling EPR. This technique was
chosen because the lineshape is highly sensitive to the motion of the nitroxide spin label, which
is a reflection of the local structural environment. In one case, we attached the nitroxide to an
engineered single cysteine at position 42 in the N-terminal region of SN and in another case, the
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nitroxide was attached at position 74 in the C-terminal region of SN (Figure 2.1A). Prior to complex
formation, EPR spectra from both spin labeled mutants showed narrow lineshapes, prototypical of
a freely diffusing random coil. However, when SNAP-25 was complexed with syntaxin 1A in the
1:1 stoichiometry, we observed extensive line-broadening in both cases (Figure 2.1B). This suggests
that SN underwent a conformational change from a random coil to a helical structure at both
N-terminal and C-terminal regions upon formation of the t-SNARE complex.
We still observed some narrow components in the EPR spectra, which represent signals from
an unstructured polypeptide. The percentage of the narrow spectral components was quantita-
tively determined with the spectral subtraction method24 (Figure 2.1C). We found that the narrow
components were approximately 5–10% of the composite spectra (Figure 2.1D). These numbers
are consistent with the previously reported dissociation equilibrium of the 1:1 binary t-SNARE
complex, where Kd ∼0.4 µM25. One could argue that the narrow component may have been due
to the predominant existence of the 2:1 complex in the 1:1 mixture. However, if this were the case,
a much larger narrow component would be observed due to the significant fraction of SNAP-25
remaining as monomers.
We then investigated the structure and dynamics of SC in the 1:1 complex using EPR. We
generated five single cysteine mutants: G168C, T173C, N175C, N196C, and L203C of SC. These
mutants were specifically selected to be around the central conserved residue Q174 (zero layer); two
were positioned on the N-terminal half and three were positioned on the C-terminal half (Figure
2.1A). As monomers, all spin labeled SNAP-25 mutants displayed a narrow EPR spectra similar
to what was observed with the SN, indicative of a freely diffusing polypeptide chain with little
secondary or tertiary structure. However, when bound to syntaxin 1A all positions except 203C
exhibited a composite two component spectra with one broad component reflecting the structured
species and another narrow component reflecting the unstructured species (Figure 2.1E and F).
We did not observe much spectral change with 203C, consistent with the previous finding that the
C-terminal end is frayed for the 1:1 complex26.
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Quantitative spectral subtraction analysis revealed that approximately 40% of SC was unstruc-
tured (Figure 2.1F), which was 4 times more than what was expected from the dissociation equilib-
rium between syntaxin 1A and SNAP-25. Taking into account the global association-dissociation
equilibrium, we estimate that approximately 30% of SC remains unstructured when SNAP-25 is
complexed with syntaxin 1A (Figure 2.1F). Thus, the results show that a significant fraction of
SC (∼30%) is unstructured while SN is complexed with syntaxin 1A. The results are partially
consistent with the dynamic structure proposed by An and Almers in that SC has the tendency to
dissociate from the complex23. However, our observations suggest that the majority of SC (∼70%)
is still bound to syntaxin 1A and SN and together they form a three helix bundle (Figure 2.1G).
2.3.2 Cleavage of SC by botulinum toxins increases the dynamics of SC
Having characterized the 1:1 t-SNARE complex with EPR, we investigated the impact of the
proteolytic cleavage of SC by BoNT A and E. To this end, we prepared recombinant SNAP-25
mutants of reduced lengths, SNAP-25A (aa. 1-197) and SNAP-25E (aa. 1-180). For SNAP-25A
and SNAP-25E, we attached nitroxide spin labels at the same positions as those of the wild-type
described in the previous section (Figure 2.2A).
For spin labeled positions 42 and 74 on SN, not much difference in the spectral line shape
between wild-type SNAP-25 and the shortened mutants was observed. Further quantitative spectral
subtraction analysis confirmed that the amounts of the narrow spectral components reflecting the
global dissociation of the t-SNARE complex remained within ± 5% (Figure 2.2B). This suggests
that BoNT A or E-induced cleavage of SNAP-25 does not alter the stability of SN in the t-SNARE
complex.
However, when we examined the EPR spectra from SNAP-25E, the broad spectral components
reflecting the structured conformation was reduced significantly (Figure 2.2C). Quantitative spec-
tral subtraction analysis showed that the bound fraction was decreased for SNAP-25E as much as
∼55% for the spin labeled positions in SC (Figure 2.2D). Thus, our results show that the cleavage
of 26 residues of SC causes the dynamic destabilization of the already dynamic t-SNARE complex.
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In contrast, the dynamic destabilization that was brought about by the cleavage of SC by BoNT
A appeared to be milder than what was observed with the cleavage by BoNT E27. The effect is
pronounced on positions 175 and 196, which are located in the C-terminal half of SC. In contrast,
the change is not visible in the N-terminal half. Thus, the EPR analysis shows that while BoNT E
affects the dynamics of the entire SC motif, the effect of BoNT A cleavage is confined within the
C-terminal half of SC.
2.4 Discussion
It is well established that BoNTs inhibit neurotransmitter release from the neuron by site
specifically cleaving SNAREs17,27. However, the underlying molecular mechanisms by which the
BoNT-shortened SNAREs fail to elicit neurotransmitter release are not clearly understood.
In this work, I investigated the effects of SNAP-25 cleavage by BoNT A and E on the initial
interactions with syntaxin 1A with EPR. By employing this technique, I were able to comprehen-
sively dissect how cleavage of SNAP-25, by BoNT A and E, impacts SNARE-mediated membrane
fusion from the very early steps of SNARE assembly. In comparison to the wild type SNAP-25, the
EPR results show that the cleavage of 26 residues at the C-terminal end by BoNT E significantly
destabilizes the C-terminal SNARE motif (SC). Importantly, the destabilization infiltrates into the
N-terminal half which serves as the nucleating core for the interaction with VAMP2.
While the EPR spectra show that SNAP-25E destabilizes the entire SC motif, SNAP-25A
appears to have a milder effect and the destabilization was confined within the C-terminal half of
SC. The results suggest that the structural integrity of the N-terminal core of the t-SNARE complex
is still preserved despite the deletion of the 9 residues at the C-terminus. Taken together, the results
suggest that BoNT A tampers with membrane fusion just prior to the fusion pore formation step,
in sharp contrast to BoNT E which inhibits at the very early step of SNARE complex formation.
It is remarkable that, despite only being a 17 residue difference in length, SNAP-25A and E
terminate membrane fusion at completely different steps along the fusion pathway. While SNAP-
25A is able to support robust docking, SNAP-25E loses its ability to interact with VAMP2 almost
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completely, seriously impairing vesicle docking. Our results are in line with the previous observation
in the presynapse that the size of the readily releasable vesicle pool for the BoNT A-treated neuron,
determined by the high K+ treatment, is similar to the control, while that for the BoNT E-treated
neuron is significantly reduced27. Furthermore, our results show that the C-terminal part of SC
plays an important role in maintaining the stability of the N-terminal core of the t-SNARE complex,
which is necessary for the interaction with VAMP2. For SNAP-25A, the t-SNARE core is able
to tolerate the loss of C-terminal 9 residues. However, the loss of 26 residues in SNAP-25E is
sufficiently large to disrupt the stability of the N-terminal core of the t-SNARE complex.
Now one might ask why SNAP-25A is able to lead the membrane fusion process up to docking,
but utterly fail thereafter. One possible scenario could be that, although not significant individu-
ally, this effect could be amplified due to the expected cooperativity among the multiple SNARE
complexes that are believed to participate at the active zone35. We also note that the membrane
proximal C-terminal region of the SNARE complex plays an important role when interacting with
synaptotagmin 1 and complexin26,36,37. Thus, we cannot rule out the possibility that the loss of 9
residues in SNAP-25A hampers the necessary interaction with the accessory proteins.
In the past, clostridial neurotoxins, including BoNT A and E, have played a crucial role in
revealing SNAREs as the core fusion machinery for neurotransmitter release16,20,38. In this study,
we performed a comprehensive analysis of their impact on the structure and dynamics of SNARE
complex and consequential effects on membrane fusion steps. The results from this study reveal
new insights into the mechanism by which SNARE complex formation is coupled to individual
fusion steps.
2.5 Materials and methods
2.5.1 Plasmid construction and mutagenesis
DNA sequence encoding: syntaxin 1A (amino acids 1-288 with three cysteines replaced by
alanines), SNAP-25 (amino acids 1-206 with four native cysteines replaced by alanines), SNAP-
25A (amino acids 1-198), SNAP-25E (amino acids 1-180), and VAMP2 (amino acids 1-116 with 1
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cysteine replaced by alanines) were inserted into the pGEX-KG vector as GST fusion proteins. All
cysteine mutants, including SNAP-25 A42C, SNAP- 25 A74C, SNAP-25 G168C, SNAP-25 T173C,
SNAP-25 N175C, SNAP-25 N196C, and SNAP-25 L203C were generated by the QuickChange site-
directed mutagenesis kit and confirmed by DNA sequencing (Iowa State University DNA Sequencing
Facility).
2.5.2 Cell culture
All recombinant proteins were expressed in Escherichia coli BL21 (DE3) bacterial strain cells.
Cells were first grown in LB medium at 37◦C with shaking at 200 rpm until optical density reached
0.6–0.8 (600 nm). Isopropyl-β-D-thiogalactopyranoside (IPTG) (0.4 mM final concentration) was
added to induce protein expression. After induction cells were further incubated at 16◦C, shaking
at 100 rpm for another 14–16 h.
2.5.3 Protein purification
For GST-tagged proteins, cells were pelleted and resuspended in 15 mL of PBST (PBS, pH 7.4,
containing 0.2 Triton X-100) for membrane proteins and 15 ml of PBS (pH 7.4) for the soluble
proteins with final concentrations of 1 mM 4-(2- aminoethyl)- benzenesulfonyl fluoride (AEBSF)
and 4 mM DTT. Cells were lysed by sonication on ice and centrifuged at 25,000 g for 30 min at
4◦C. The cleared supernatant was nutated with 2 ml of GST beads for 1 hour at 4◦C.
After intense washing, the bound proteins were then eluted by 0.02 unit/µL thrombin in cleavage
buffer (PBS, pH 8.0, containing 2 mM DTT) with/without 0.8 N-octyl-D-glucopyranoside (OG)
for GST-tagged membrane and soluble proteins, respectively Purified proteins were examined by
SDS-PAGE (15%, w/v) and the purity was at least 85% for all proteins. The protein concentration
was determined using RC DC kit.
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2.5.4 Site-directed spin and fluorophore labeling
For site-directed spin labeling of single cysteine mutants for EPR, the protein were incubated
with 5 mM dithiothreitol (DTT) for 1 hour at 4◦C. The protein was then subjected to the PD-10
size exclusion column and incubated for 16 hours at 4◦C with 10-fold molar excess of 1-Oxyl-2,2,5,5-
tetramethylpyrroline-3-methyl methanethiosulfonate (MTSSL). The proteins were then subjected
to another PD-10 size exclusion column to remove any excess spin labels.
For site-directed fluorophore labeling of single cysteine mutants, the proteins were desalted
with a PD MiniTrap G-25 column to eliminate free DTT and then incubated with a 10-fold molar
excess of maleimide-derivative fluorophore indodicarbocyanine (Cy5) or indocarbocyanine (Cy3),
respectively, overnight at 4◦C. The labelled protein was purified using the PD MiniTrap G-25
column and free dye was further separated from the protein sample using centrifugal filters (3 kDa,
Amicon Millipore Corporation, Bedford, MA). The labeling efficiency of each SNARE protein was
measured spectrophotometrically (NanoDrop 2000c Spectrophotometer, Thermo Fisher Scientific,
Waltham, MA). Further details can be found in our recent paper28.
2.5.5 EPR data collection
EPR spectra were obtained using a Bruker ESP 300 spectrometer (Bruker, Germany) equipped
with a low-noise microwave amplifier (Miteq, Hauppauge, NY) and loop gap resonator (Medical
Advances, Milwaukee, WI). The modulation amplitude was set at no greater than one-fourth of
the line width. Spectra were collect at room temperature in the first-derivative mode.
2.6 Quantification and Statistical Analysis
2.6.1 EPR data analysis
The Bruker Xepr software was used to collect all EPR spectra (Figure 2.1B, 2.1E, 2.2B, and
2.2C). The spectral subtraction method involves obtaining the EPR spectra of the monomer and
the composite at the same position. The monomer was subtracted from the composite in order to
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determine the amount of monomer present (Figure 2.1C). This was used to quantitatively determine
the population of mobile and immobile spin labeled proteins (Figure 2.1D, 2.1F, and 2.2D).
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Figure 2.1 EPR spectra and analysis of spin-labeled SNAP-25 as monomers and part of
the 1:1 binary t-SNARE complex.
(A) Schematic representation of the site-directed spin labeling EPR of the t-SNARE complex
with syntaxin 1A (red) and SNAP-25 (green). SNAP-25 is denoted with spin labeled positions
and BoNT A and E cleavage sites. The conserved zero layer is represented by a dashed line. The
inset depicts chemical structure of the spin label (MTSSL) attached to the cysteine side chain.
(B) Room temperature EPR spectra for A42C and A74C in the SN domain in monomeric
SNAP-25 or in the t-SNARE complex. (C) Representative EPR spectral subtraction analysis.
The composite binary EPR spectrum (black) was subtracted by the monomer spectra (red) to
obtain the broad, interacting spectral component (blue). (D) Bound fraction of the labeled
positions (SN domain) in the t-SNARE complex obtained from the spectral subtraction analysis.
The data are shown as means SD. (E) Room temperature EPR spectra for the labeled positions
in the SC domain in monomeric SNAP-25 or in the tSNARE complex. The red arrow indicates
areas of EPR lineshape broadening. (F) Bound fraction of the labeled positions (SC domain) in
the t-SNARE complex obtained from the spectral subtraction analysis. The average bound
fraction (red) of spin labeled positions G168C, T173C, N175C, and N196C is 0.61. Position 203
was excluded when calculating the mean due to its position being near the end the SC domain
which is known to be frayed and unstructured. The data are shown as means ± SD. (G) Model of



































































Figure 2.2 EPR spectra and analysis of spin-labeled SNAP-25, SNAP-25A, and SNAP-25E
as monomers or part of the 1:1 binary t-SNARE complex.
(A) Schematic representation of the site-directed spin labeling positions of SNAP-25, SNAP-25A
and SNAP-25E. The zero layer is denoted by a dashed line. (B) Room temperature EPR spectra
of SNAP-25, SNAP-25A and SNAP- 25E spin labeled variants on the SN motif as monomers or
part of the t-SNARE complex. (C) EPR spectra of SNAP-25, SNAP-25A, and SNAP-25E spin
labeled variants on the SC motif as monomers or part of the t-SNARE complex. The red arrows
point to the broad component of the EPR spectra. (D) Bound fraction of the labeled positions in
the t-SNARE complex obtained from spectral subtraction analysis for SC and SN motifs are
shown in the left and right graph, respectively. The data for SNAP-25 (black circle), SNAP-25A
(orange triangle), and SNAP-25E (blue rectangle) are shown as means ± SD.
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SNARE complex formation, which is believed to drive intracellular membrane fusion, transits
through multiple conformational states along the membrane fusion pathway. The SNARE interme-
diates are biologically important because they serve as targets for fusion regulators and clostridial
neurotoxins. Spin labeling EPR has contributed significantly to the understanding of the struc-
tures and the dynamics of SNARE intermediates. In particular, the EPR lineshape analysis, which
is highly sensitive to protein conformational changes such as the local coil-to-helix transition, has
revealed the sequential compacting steps leading to formation of the highly stable four helix bundle.
3.2 Introduction
3.2.1 Layered complexity of SNARE complex formation
It is now widely believed that SNARE proteins, which are highly conserved from yeast to human,
drives intracellular membrane fusion1,2. The vesicle (v-) SNARE protein associates with the target
membrane (t-) SNARE proteins to form a complex that brings about apposition and subsequently,
fusion of two membranes. The SNARE complex is the fusion machine that provides the necessary
free energy to overcome the energy barrier for fusion of two separate membranes that are otherwise
individually highly stable when undisturbed.
The most critical piece of information to understand the mechanism of SNARE-dependent
membrane fusion may be the three dimensional structure of the SNARE complex. The SNARE
core complex is a highly stable, all parallel four-stranded coiled coil3–5 that forms its parallel
structure when it brings two membranes into close proximity. The high stability of the structure
ensures the merge of two membranes. This stable formation justifies its structural and energetic
role as the core fusion machine.
Equally important is the pathway through which the SNARE complex is assembled. Some
SNARE-dependent membrane fusion (for example, synaptic vesicle fusion) is tightly regulated by
auxiliary proteins including Ca2+-sensor synaptotagmin 1 and sec1/munc (SM) family proteins6. It
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is believed that auxiliary proteins target the SNARE folding intermediates7. Thus, the structural
investigations of SNARE folding intermediates appear to be essential towards the understanding
of the mechanisms whereby the auxiliary proteins regulate membrane fusion.
At early stages, two t-SNARE proteins, one in the syntaxin family and the other in the SNAP-
25 family, assemble into a 1:1 t-SNARE complex, which will serve as the receptor for v-SNARE. In
the t-SNARE complex, one SNARE motif (∼70 residue-long heptad repeat) from the syntaxin-1A
and two N- and C-terminal SNARE motifs from SNAP-25 form a highly dynamic, three-stranded
coiled coil, where the C-terminal SNARE motif of SNAP-25 has tendency to uncoil to a great
extent8,9. Adding to the complexity, there is evidence that association of v-SNARE with the
t-SNARE complex occurs in multiple (at least two) sequential steps: The assembly starts from
the membrane-distal N-terminal region and proceeds towards the membrane-proximal C-terminal
domain10, thereby driving a gradual apposition of two membranes. The folding intermediates
are likely to be transient and meta-stable and thus, offer formidable challenges for structural
investigations11–13.
3.2.2 Spin labeling EPR on SNARE complex formation
Over the years, spin labeling EPR has contributed significantly to the understanding of the
structure and dynamics of the SNARE core complex and its folding intermediates. In sitedirected
spin labeling EPR14, a specific, selective residue is replaced with a unique cysteine and the cys-
teine is labeled with an EPR-active nitroxide. EPR of spin labeled mutants offers three powerful
experimental avenues to explore the structure and the function of SNARE complexes15. The first is
the distance measurement between two site-specifically attached nitroxides within the complex16.
The distance measurement method has been used to determine the first four-helix bundle structure
of the SNARE core complex3, the structure of the t-SNARE complex that is consist of syntaxin
and SNAP-25 in the 2:1 stoichiometry17,18, and the conformational change of the transmembrane
domain (TMD) of v-SNARE caused by cholesterol19. The detailed methods and the experimen-
tal protocols are extensively described in the Method in Molecular Biology article by Oh et al.
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The second is the measurements of accessibilities to non-polar O2 and polar, soluble paramagnetic
NiEDDA, the ratio of which is used to measure the membrane immersion depth of the nitroxide
attached to the membrane-embedded polypeptide20. The method is grossly empirical. Neverthe-
less, it has proven to yield fairly accurate estimation of the membrane immersion depth. To be
an effective fusion machine, the SNARE complex must be able to transfer the force generated by
the core region to the transmembrane domains. We believe that the linker region acts as the force
transducer. The EPR accessibility measurements reveal that despite highly basic nature of the
both v- and t-SNARE linker regions, they are immersed into the membrane with some secondary
structures21–24. Thus, they help make a tight connection between the SNARE core and the trans-
membrane domain and may structurally qualify as the effective force transducer. Furthermore,
the determination of the structure of the v-SNARE TMD laid the groundwork for designing the
mutant that traps the hemifusion intermediate, leading to the first time discovery of hemifusion in
SNARE-dependent membrane fusion25.
3.2.3 EPR lineshape analysis to peel off layers of SNARE complex formation
The third avenue, which is the main focus of this chapter, is the EPR lineshape analysis, taking
advantage of the EPR’s superb sensitivity to the motional rate of the nitroxide26. For example,
the folding of a polypeptide from a random coil to an α-helix or the binding of the unstructured
polypeptide to the membrane gives rise to a dramatic lineshape change from a narrow, fast motional
spectrum to a fairly broad, intermediate motional spectrum, which are visually distinguishable
from each other. If the nitroxide makes an additional tertiary or steric contact, the lineshape
change is even more profound to become very broad which reflects very severely restricted motion.
SNARE complex formation involves these types of conformational changes which are accompanied
by dramatic EPR lineshape changes for the nitroxide attached to SNARE motifs.
SNARE motifs, when not in the complex, are mostly unstructured and freely moving in solution,
resulting in sharp, fast motional EPR spectra for the nitroxides. However, when complexed with
other SNARE partners, the motional rate of the nitroxide slows down significantly and the EPR
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lineshape becomes broad23,24. Very interestingly, however for long SNARE complexes in particular,
a conformational change could be localized specifically to a certain part of the protein. For example,
SNARE zippering is expected to transition through a partially folded conformation in which the
N-terminal coiled coil is intact while the C-terminal region is frayed. The EPR lineshape analysis
is uniquely suited to investigate such local conformational changes and has proven powerful in
characterizing the structures of SNARE folding intermediates9,27.
For the SNARE complex, its working environment is the narrow gap between two closely ap-
posed membranes. However, most structural studies have been carried out by employing isolated
proteins, away from such a special situation. Thus, more often than not, the interpretation of the
structural outcomes is often ambiguous. Alternatively, the recently advanced nanodisc technology
makes it possible to create the membrane platform that mimics the native-like environment for
SNARE complexes. One could place a single SNARE complex within a two nanodisc sandwich by
reconstituting t- and v-SNAREs to separate nanodiscs and allowing them to form the trans complex
between the two nanodiscs. Such an experimental platform has been successfully constructed and
the structure of the SNARE complex has been examined using the EPR lineshape analysis13. The
results are exciting and reveal that a half zippered SNARE complex in which the C-terminal half of
v-SNARE, which is the downstream of conserved middle 1R3Q layer, is free while the N-terminal
half of the SNARE complex is an intact coiled coil has been identified as a likely metastable fusion
intermediate.
Although the lineshape analysis is the least explored avenue of spin labeling EPR in structural
biology, it has been instrumental in characterizing the structure and the dynamics of SNARE
folding intermediates in the native-like environment. Additional contribution with this approach
include, but not limited to, the characterization of partially folded t-SNARE core9 and structural
disruption of the C-terminal region of the SNARE complex by the membrane27. Overall, EPR
has shown to be a powerful technique in observing the structural transitions in SNARE complex
formation (Figure 3.1). In this chapter, we will review the protocols of the sample preparations,
EPR experiments, and data analysis for the EPR lineshape analysis on SNARE proteins.
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3.3 Materials
1. Primers: Synthesized by the Iowa State DNA facility.
2. QuikChange Kit: Agilent Technologies QuikChange Site-Directed Mutagenesis Kit.
3. Thermocycler: MJ Mini Thermal Cycler.
4. Restriction enzyme Dpn1: FastDigest DpnI.
5. PCR cleanup kit: QIAquick PCR Purification Kit.
6. Nanodrop: Thermo ScientificTM NanoDropTM 2000 Spectrophotometer.
7. 10 mg/mL tetracycline: 100 mg of tetracycline is added to a final volume of 10 mL of double-
deionized water (ddH2O). Store at -20◦C.
8. E.coli XL1 Blue and BL21 DE3 competent cells.
9. Luria broth (LB): 25 g/L of premixed 10 g/casein digest peptone, 10 g/L sodium chloride, and
5 g/L yeast extract are dissolved in ddH2O and autoclaved.
10. 100 mg/mL ampicillin: 1 g of ampicillin is dissolved into a final volume of 10 mL ddH2O.
Store at -20◦C.
11. 50 mg/mL kanamycin: 0.5 g of kanamycin is dissolved into a final volume of 10 mL ddH2O.
Store at -20◦C.
12. QIAprep Spin Miniprep Kit.
13. 1 M isopropyl-β-D-thiogalactopyranoside (IPTG): 2.38 g of IPTG is dissolved in a final volume
of 10 mL ddH2O. Store at -20◦C.
14. Centrifuge and rotors: A Beckman Coulter Avanti J-25 centrifuge is used in conjunction with
a JA-14 rotor for cell pelleting and a JA-25.5 rotor for spinning down cell lysate.
15. 10X Phosphate-buffered saline (PBS): 137 mM NaCl, 2.7 mM KCl, 10 mM Na2PO4, and 1.8
mM KH2PO4 with a pH of 7.4. The pH is not adjusted. Store at 4◦C.
16. Phosphate-buffered saline with triton (PBST): Generated from 10X PBS. Final concentration
of 137 mM NaCl, 2.7 mM KCl, 10 mM Na2PO4, 1.8 mM KH2PO4 and 0.4% Triton X-100 with a
pH of 7.4. Store at 4◦C.
17. 1 M DL-dithiothreitol (DTT): 1.54 g of DTT is dissolved in a final volume of 10 mL ddH2O.
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18. AEBSF: 0.25 g of AEBSF is dissolved in a final volume of 5 mL ddH2O. Store at -20◦C.
19. 20% N-lauroylsarcosine: 2 g of N-lauroylsarcosine is dissolved in a final volume of 10 mL
ddH2O. Store at 4◦C.
20. GSH beads: Glutathione Agarose Beads.
21. Phosphate-buffered saline with N-ocytl-B-D-glucopyranoside (PBS-OG): Generated from 10X
PBS. Final concentration of 137 mM NaCl, 2.7 mM KCl, 10 mM Na2PO4, 1.8 mM KH2PO4 and
0.8% OG with a pH of 7.4. Store at 4◦C.
22. Thrombin.
23. Glycerol.
24. Bio-rad RC DC Protein Assay Kit II.
25. Spin concentrators: Amicon R© Ultra – 0.5mL Centrifugal Filters Ultracel R© - 3K.
26. Desalting column: PD MiniTrapTM G-25 (GE Healthcare).
27. 100 mM MTSSL: 50 mg methanethiosulfonate (MTSSL) (Fisher Scientific) is added to 1.89
mL of acetonitrile. Store at -20◦C wrapped in aluminum foil.
28. 100 mM TEMPOL: Add 172 mg of 4-Hydroxy-TEMPO (Sigma Aldrich) to a final volume of
100 mL ddH2O. Store at 4◦C.
29. Bruker Elexsys E500 X-band EPR spectrometer equipped with the loop-gap resonator (Medical
Advances) and a low-noise microwave amplifier (Militech).
30. XEPR: Bruker Xepr software suite version 2.6b.54 is used in Linux (OpenSuse 11.3).
31. Lipids: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1,2- dioleoyl-sn-glycero-
3-phospho-L-serine (DOPS) are removed from their vials and transferred to amber, glass bottles.
All bottles are capped, sealed with parafilm, and vacuum sealed for storage. Store at -20◦C in the
dark.
32. 100 mg/mL cholesterol: 100 mg of cholesterol powder is dissolved to a final volume of 1
mL using chloroform in an amber, glass bottle. All bottles are capped, sealed with parafilm, and
vacuum sealed for storage. Store at -20◦C in the dark.
33. Vacuum desiccator: Bel-ArtTM SP SciencewareTM Space Saver Vacuum Desiccators.
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34. Kimtech wipes: Kimberly-ClarkTM Professional Kimtech ScienceTM KimwipesTM Delicate
Task Wipers, 1-Ply.
35. Phosphate-buffered saline (10% OG): 100 mg of OG is added to 100 µL of 10X PBS. The final
volume is adjusted to 1 ml with ddH2O. Store at room temperature.
36. 500 µM sodium cholate: 3α,7α,12α-Trihydroxy-5β-Cholan-24-Oic Acid (Anatrace). 215 mg of
sodium cholate is dissolved in a final volume of 1 mL using T150. It is very important that this
comes from a company that synthesizes it, not one that purifies it from a biological source. The
enzyme contaminants in the biologically purified sodium cholate will degrade lipids and membrane
proteins.
37. Apo-A1 is recombinantly expressed and purified (see Note 10).
38. T150 buffer: 10 mM tris base and 150 mM sodium chloride. This pH is adjusted to 7.4. Store
at 4◦C.
39. Bio-Beads: Bio-Beads SM-2 Resin (Bio-Rad). A 1:1 solution of bio-beads in T150 is made by
treating the bio-beads with methanol to remove air and equilibrating to desired buffer. Add 10 mL
of bio-beads to a 25 mL batch column. The bio-beads are washed with 10 column volumes (CV)
of methanol, ensuring that the bio-beads are constantly submerged. At the end of the last wash,
immediately wash with another 10 CV of T150 (or buffer of choice). Near the end of the last wash,
cap the tip of the column, fill the column 20 mL with T150 (or buffer of choice), and transfer the
bio-beads to a 50 mL tube for storage at 4◦C.
40. FPLC: BioLogic DuoFlow 10 System Fraction collector (Bio-Rad).
41. Size exclusion column (SEC): GE Healthcare Life Science Superdex 200 10/300 GL.
42. Ni-NTA Agarose Resin: Thermo ScientificTM HisPurTM Ni-NTA Resin.
43. 5 M imidazole: 17.02 g of imidazole is dissolved in a final volume of to 50 mL ddH2O. The pH
is corrected to 7.4. Store at 4◦C wrapped in aluminum foil.
44. EPR sample loading tips: FisherbrandTM Gel-Loading Tips, 0.5–10 µL.
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45. Capillary tubes: Borosilicate capillary tubes with an internal diameter (i.d.) of 0.6 mm and
an outer diameter (o.d.) of 0.84 mm (VitroCom) are sealed at one end with a Bunsen burner.
46. Ethanol.
3.4 Methods
3.4.1 Generation of cysteine mutant plasmid
1. Design primers (see Note 1).
2. Site-directed mutagenesis. The thermocycler is set at following protocol: Heat lid to 105◦C,
98◦C for 2 minutes, 98◦C for 15 seconds, 55◦C for 1 minutes, 68◦C for 5.5 minutes, repeat steps
2–4 for 16 cycles (17 cycles in total), 68◦C for 11 minutes, 4◦C until stopped.
3. Transformation into E. coli XL1 Blue competent cells (see Note 2). 100 ng of purified mutant
plasmid is transformed into ∼50 µL XL1 Blue competent cells. Transformed cells are incubated
with 1 ml Luria Broth (LB) at 37◦C for 1–2 hours shaking at 200 rotations per minute (rpm).
After incubation, the cells are plated onto ampicillin plates and incubated upside down at 37◦C for
16–18 hours.
4. Screen for the desired mutation. Pick off 3–5 isolated colonies with different sterile pipette tips
and add each colony to separate 50 mL sterile tubes containing 10 ml LB-amplicllin (100 µg/mL).
Cap the tubes, but do not screw on the cap tightly. If necessary, tape the cap on to prevent it from
falling off. Incubate the colonies for 16–18 hours at 37◦C while shaking at 200 rpm.
5. Purifying amplified plasmids. The DNA concentration is measured using a Nanodrop in the
dsDNA nucleic acid mode.
6. Plasmids are sequenced by the Iowa State University DNA facility using Sanger Sequencing and
sequences are aligned with the wild-type sequence to verify that only the desired mutation is made.
32
3.4.2 Purification of recombinant proteins
1. Transform verified cysteine mutant plasmid into E. coli BL21 (DE3) competent cells.
2. Grow the starter culture. Follow the same protocol as 3.1 step 4.
3. Grow a large culture. Inoculate 500 mL of LB-amp with 5 mL of the starter culture and incubate
at 37◦C while shaking at 200 rpm until the optical density at 600 nm (OD600) reaches 0.6–0.8.
Chill for at least 30 minutes at 4◦C, induce with 150 µL of IPTG (1 M), and incubate at 16◦C and
200 rpm for 16–18 hours.
4. Lyse the cells. After induction, pour out the large culture into 250 mL centrifuge tubes. Pellet
the cells by centrifuging at 4◦C for 10 minutes at 3,800 x g in a JA-14 rotor. Once cells are pelleted,
pour out the supernatant and resuspend the cells in 20 mL of lysis buffer (see Note 3). Add 75
µL DTT (1 M), 30 µL AEBSF (50 mg/ml), and 150 µL N-lauroylsarcosine (20% w/v) to the
resuspended cells. Lyse cells using a homogenizer. Lysate should change from a viscous opaque
color to a fluid clear color indicating successful lysis.
5. Bind protein to affinity beads. Add the lysate to 50 mL centrifuge tubes and centrifuge with at
4◦C for 30 minutes at 27,200 x g in a JA-25.5 rotor. While the lysate is centrifuging, add ∼1 mL
of GSH beads to a 25 mL batch column and wash with 3 column volumes (CV) of ddH2O, then 1
CV of lysis buffer to equilibrate the column ensuring the beads stay continuously hydrated. Cap
the tip of the column and add the supernatant from the centrifuged lysate to equilibrated beads.
Cap the top of the column and nutate the mixture at 4◦C for ∼2 hours.
6. Purify the protein of interest. After ∼2 hours, drain the supernatant from the column by first
removing the cap from the top of the column and then the cap from the tip of the column. Wash
the beads with 5 CV of lysis buffer. After washing, the beads are buffer-exchanged into their elution
buffers (see Note 3). Buffer exchange by adding three 1 mL aliquots to the washed beads. Let
each aliquot fully flow through before adding the next. Cap the tip of the column and add 1 mL
of elution buffer and 30 µl of thrombin (1U/µl) to the buffer-exchanged beads. Cap the top once
all the contents are added. Cleave off the purified protein by either incubating the column at room
temperature for 1.5 hours or 4◦C for 16 hours. Ensure homogenous distribution of the thrombin.
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7. Elute purified protein. Remove the cap off the top of the column first and then remove the cap off
tip of the column over an Eppendorf tube to collect the first fraction. Elute the remaining protein
by adding 1 mL aliquots of the elution buffer to the beads and collecting. Significant amounts of
protein should appear in the first three fractions. Add 177 µL of glycerol to each 1 mL fraction
making the final solution 15% glycerol (v/v). Glycerol serves as a cryo-protectant for storage at
-80◦C.
8. Check the protein purity. Hand cast 12% SDS-PAGE gels according to the BioRad protocol
(Bio-Rad: Handcasting Polyacrylamide Gels). Aliquot out 10 µl of the eluted protein (see Note 4).
Add 5X SDS-PAGE loading dye to purified protein so that volume ratio of dye to protein is 1:4.
Load the gel into the electrophoresis system and load the entire protein-dye sample along with a
protein ladder into the wells. Run at 40 mA for 35 minutes for a single gel or 60 minutes for two.
9. Estimate the protein concentration. Use the Bio-Rad RC DC kit (Bio-Rad: RC DC Protein
Assay) and protocol to estimate the protein concentration. Concentrate and store at -80◦C (see
Note 5).
3.4.3 Spin Labeling Recombinant Proteins
1. Reduce protein for efficient spin labeling. An aliquot of purified protein is thawed on ice. The
protein is then diluted to a final volume of 500 µL in a solution of PBS + DTT (5 mM). This
mixture simultaneously reduces the cysteines and prepares the protein for the PD-10 desalting
column. The mixture is incubated for 30 minutes at 4◦C. While the protein is being reduced, the
desalting columns are prepared by pouring off the storage buffer and equilibrating with 3 CV of
elution buffer. Calculate the volume of MTSSL in order to have the spin label : protein ratio at
10 : 1 (see Note 6). After incubation, the mix is added to the equilibrated desalting column. Once
the mixture has fully loaded into the column, 1 mL of elution buffer is used to elute the reduced
protein off the column. The flow through from this step contains the reduced protein and should
be collected.
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2. Spin label reduced protein. Add the calculated volume of MTSSL as soon as reduced protein
elutes from the desalting column. The protein is spin labeled overnight by nutating for 16–18 hours
at 4◦C.
3. Remove excess spin label. Concentrate the labeled protein to 500 µL using a 3K spin concentra-
tor. During the centrifugation, prepare another desalting column as in 3.3 step 1. A concentration
cycle should be about 14,000 x g at 4◦C for 8 minutes with resuspension between cycles to prevent
aggregation. Load the concentrated spin labeled protein onto the equilibrated PD-10 desalting
column. This desalting column removes a majority of the excess MTSSL from the labeled protein.
Elute the spin labeled protein and collect.
4. Remove residual excess spin label. Spin wash the eluted labeled protein by concentrating it to
∼250 µL in a new 3K spin concentrator and then filling the remaining portion of the spin concen-
trator full of elution buffer. Use the same concentration cycle procedure as in 3.3 step 3. Three spin
wash cycles should remove the remaining of excess MTSSL. Re-estimate the protein concentration
using the Bio-Rad RCDC kit (Bio-Rad: RC DC Protein Assay).
5. Measuring labeling efficiency (see Note 7). EPR spectra of TEMPOL standard solutions of
known concentrations are collected. The EPR spectra are processed by correcting for the baseline
and double integrating. These double integration values are plotted against the spin concentrations
to generate a standard curve. The EPR spectrum of the spin labeled protein of a known protein con-
centration is measured and processed under the same conditions as the TEMPOL standards. The
spin label concentration of the protein sample is determined by comparing its double-integration
value with the TEMPOL standard curve. The spin label concentration of the protein sample is
then divided by the protein concentration determined by the Bio-Rad RCDC kit (Bio-Rad: RC DC
Protein Assay) to obtain the spin-labeling efficiency. Spin labeling efficiencies using our method
are usually over 90%.
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3.4.4 Reconstitution of spin labeled protein into nanodiscs
1. Prepare the stock lipid mixture. Lipids are carefully mixed in a glass tube so that when resus-
pended in 100 µL of T150 buffer, the total lipid concentration is 50 mM. The final lipid mixture of
PC : PS : cholesterol is at a molar ratio of 65 : 15 : 20. The chloroform in the mixture is evapo-
rated under an air stream to dry the lipids. The dried lipid film is placed in a vacuum desiccator
at room temperature overnight (16–18 hours) (see Note 8). Resuspend with 100 µL of T150 buffer
by incubating in a 42◦C water bath for 1 minute and vortexing for 1 minute. Repeat until the lipid
film has been resuspended. The lipid stock can be stored at -80◦C for ∼2 weeks.
2. Preparing nanodisc mixture. Section 3.4 steps 2–3 are summarized in Figure 3.2. The goal is
for the end product of lipids : labeled protein : Apo-A1 to be at a molar ratio of 400 : 1 : 4. This
will be referred to as the nanodisc mixture. 5 µL of the lipid stock solution is added to sodium
cholate so that the final concentration of sodium cholate in the nanodisc mixture is 50 mM. This
mixture is incubated on ice for 5 minutes.
3. Adding SNAREs to the nanodisc mixture (see Note 9). The v- and t-SNARE proteins are added
to the separate sodium cholate lipid mixtures. The proteins are added in a lipid : protein ratio of
400 : 1. When incorporating the t-SNARE proteins, Stx is used to determine the 400 : 1 ratio.
This mixture is incubated on ice for 5 minutes. Apo-A1 (see Note 10) is added to the mixture in
a lipid : ApoA1 ratio of 100 : 1 and it is incubated on ice for 5 minutes. His-tagged Apo-A1 is
used when incorporating t-SNAREs and untagged Apo-A1 is used for v-SNARE when forming the
trans-SNARE complex between two nanodiscs with the intention to purify the complex with the
Ni-NTA column.
4. Reconstitution of labeled SNAREs into nanodiscs. Bio-beads are added to the mixture at a 1
: 2 volume ratio. This is incubated on ice for 5 minutes and shortly spun to pellet the bio-beads.
Repeat the same process on the supernatant using the same amount of fresh bio-beads. It is easier
to collect the supernatant from the bio-beads if a small cavity is made in the pelleted bio-beads
(see Note 11). The supernatant volume is either concentrated to 120 µL using a spin concentrator
or diluted to 120 µL with T150 buffer. Filter supernatant with a Spin-X centrifuge filter and store.
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5. Purification of SNARE-reconstituted nanodiscs using size exclusion chromatography. All sam-
ples used on the size exclusion column (SEC) must be filtered and buffers must be both filtered
and degassed. Filter and degas 500 mL of T150. Wash SEC with 2 CV of filtered and degassed
T150 at 0.5 mL / minute. Inject the sample into the sample loop and load with 2 mL of T150 at
the 0.5 mL / minute flow rate. Elute with 1.5 CV of T150 at the flow rate of 0.5 mL / minute.
Nanodiscs usually elute between the 12–14 mL fractions.
6. Form trans-SNARE complex within two nanodiscs. This step can be skipped if only a single
species of the nanodisc is desired. ∼1 mL of Ni-NTA beads is added to a 25 mL batch column,
washed with 2 CV of ddH2O, and equilibrated with 1 CV of T150. The tip of the column is then
capped. Both v-SNARE nanodiscs and t-SNARE nanodiscs purified from FPLC are added to the
Ni-NTA beads, the top of the column capped, and the mixture is nutated overnight at 4◦C. The
top of the column is first opened and then the tip removed from the bottom allowing unbound
nanodiscs to run off the column. The remainder of unbound nanodiscs are washed off with 2 CV of
T150 buffer. The nanodiscs that have formed the trans-SNARE complex are eluted with 300 mM
imidazole in T150 buffer.
3.4.5 Electron paramagnetic resonance (EPR)
1. Prepare samples for EPR. This process is summarized in Figure 3.3. Pipette up 10 µL of
sample into EPR tube loading tips. Take the loaded EPR loading tip and put it in the open end
of a sealed EPR capillary tube. Place the EPR capillary tube and tip into a 15 mL tube without
the cap. The 15 mL tube is used as an adaptor to centrifuge the sample in the loading tip into the
EPR tube. Place 15 mL tube in a clinical centrifuge at the maximum speed for 30 seconds. The
protein solution should have moved from the EPR loading tip and be settled at the bottom part
of the EPR capillary tube. Clean the EPR capillary tube by dipping it in ethanol and drying with
a Kimtech wipe. Place the EPR capillary tube in the loop-gap resonator and collect the spectrum.
Measure EPR spectra (see Note 12).
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2. Spectral subtraction. The process is summarized in Figure 3.4. All data analysis is performed
in Bruker’s EPR suite Xepr vs. 2.6b.54. Collect the EPR spectrum of uncomplexed (or unbound)
SNARE and that of the SNARE complex. The former has a narrow lineshape, reflective of freely
moving random coil while the latter has a composite (narrow + broad) lineshape, reflective of
the equilibrium coexistence of a random coil species and the structured SNARE complex (Figure
3.4A). Process the spectra using the baseline correction and the normalization functions of the Xepr
software suite. After processing, both spectra are brought back to the derivative spectral mode by
double derivatization for direct comparison (Figure 3.4B). Baseline correction is usually performed
using a 1st order polynomial linear fit to the 20 outermost data points on either end of the spectra.
Center and overlay two spectra on top of each other (Figure 3.4C). Adjust the gain of the unbound
spectrum so that the height of the 3rd peak in the unbound spectrum roughly match the height
of the shape component of the 3rd peak in the composite spectra. Subtract the unbound from the
composite to obtain the bound fraction spectrum (Figure 3.4E). Adjust the gain carefully to yield
a smooth, broad spectrum, reflecting the bound species. The adjusted gain is equivalent to the
percentage of unbound population in the composite spectrum.
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3.6 Figures
Figure 3.1 Exploring the pathway of SNARE complex formation with SDSL EPR.
A) Diagram of a disulfide-linked nitroxide side chain (MTSSL). B) The t-SNARE is in a state
where the C-helix (SC) of SNAP-25 is unstructured and highly dynamic. The dynamic structure
of the SC domain was investigated by attaching a nitroxide spin label to a sitespecific cysteine.
C) The t-SNARE is in a state where the SC is in a structured α-helix. The nitroxide spin label is
sensitive to the local environment and produces a broader EPR lineshape than the dynamic SC
does. The EPR lineshape analysis revealed that the SC is in a dynamic equilibrium, alternating
between a bound and an unbound state. D) Dynamic trans-SNARE complex in which the
N-terminal of VAMP2 is locally structured, but the Cterminus is locally dynamic. The structured
t-SNARE complex is the precursor for VAMP2 binding and SNARE complex formation. When
VAMP2 binds, SNARE zippering occurs from the N- to C-terminus. This pre-fusion state of the
SNARE complex was studied using a SNAREpin formed in the chasm of two nanodiscs. E)
Structured trans-SNARE complex. The nanodiscs allow the SNARE proteins to form the stable
four helix bundle, but stop the full progression by arresting it at a half-zippered state. F)
Cis-SNARE complex. A stable four helix bundle as a post-fusion complex. The post-fusion state
of the SNARE complex was studied within a single nanodisc.
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Figure 3.2 Reconstitution of SNARE proteins into a lipid nanodisc.
A step by step flow chart for the reconstitution of full-length SNAREs into lipid nanodiscs.
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Figure 3.3 Preparation of the sample tube for EPR.
Diagram of EPR tube assembly. The spin labeled sample is pipetted up and kept in the loading
tip. This loading tip is inserted into the top, open end of the EPR tube with the opposite side
sealed off using a Bunsen burner. The EPR tube with loading tip is then placed into a 15 mL
tube which is inserted into a centrifuge adaptor, where it is briefly centrifuged. This will make the
sample to evacuate the loading tip and fill the EPR tube from the bottom to the top. After
centrifugation, the tube is cleaned with ethanol and dried with a Kimtech wipe. The sample is
now ready for EPR.
43
Figure 3.4 Spectral subtraction analysis.
A) Raw unbound EPR spectrum (red) and raw composite (mixture of labeled unbound species
with interacting species) EPR spectrum (purple) are obtained directly from EPR. B) Both
spectra are baseline-corrected and normalized. C) The processed unbound and composite spectra
are centered and overlayed on top of each other. The point of comparison between the two
spectra is the 3rd peak indicated by the arrow. The unbound spectrum has a higher intensity
representing the spectrum when 100% are unbound. D) The gain of the unbound spectrum is
coarsely adjusted, so the height of the 3rd peak matches the composite spectra. E) The gain is
finely adjusted, so the spectral subtraction results in a bound spectrum (blue) that is smooth and
broad. The total adjusted gain is equivalent to the percentage of unbound population within the
composite spectra. This can be used to calculate the bound population in the composite spectra
as well.
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Recently, Parkinson’s disease-associated α-synuclein (αS) has emerged as an important regulator
for SNARE-dependent vesicle fusion. However, it is controversial if excessive accumulation of αS,
even in the absence of aggregation, impairs neurotransmission. Here we use a single vesicle fusion
assay with ms time resolution capable of dissecting the impact of αS on each step of membrane
fusion. Unlike the previous results from various in vitro, cellular, and in vivo studies, we find that
non-aggregated αS promotes vesicle merger even at exorbitant concentrations. The enhancement
has been seen as much as 13 fold. Delving into the kinetics of the intermediate states for vesicle
fusion reveals that αS stimulates vesicle docking without altering the dynamics of bilayer merger
(lipid mixing). However, minute amounts of soluble aggregated species abolish SNARE-dependent
bilayer merger completely. Thus, the results show that excessive accumulation of non-aggregated
αS may not be toxic for neurotransmitter release.
4.2 Introduction
Neurotransmitter release is the foundation of thought in the central nervous system. The
brain is comprised of networks of neurons joined together via synapses. Communication between
these neurons is mediated by vesicle fusion releasing neurotransmitters at the synapses. Defects
in the regulation of neurotransmission are believed to be the primary cause for many neurological
diseases. For example, the main cause for Schizophrenia is thought to be over-release of dopamine,
while for Epilepsy it may be the under-release of adenosine and glycine1. The key to a better
understanding of neurological diseases may lie in a more complete understanding of the molecular
machine responsible for synaptic vesicle fusion.
The SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) proteins
are believed to mediate synaptic vesicle fusion2–4. Vesicle-associated (v-) SNARE forms a helical
coiled coil with the target plasma membrane (t-) SNARE to drive membrane fusion5,6. Neurotrans-
mitters are released from the vesicle through the fusion pore to the synaptic cleft7. Action potential-
evoked vesicle fusion events are synchronized and happen quickly (in less than a millisecond)8. The
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synchronous release is achieved through an exquisite regulation of SNARE complex formation by
a host of regulatory proteins including the Ca2+-sensor, synaptotagmin-19–11.
Alpha-synuclein (αS) has long been a protein of great interest because of its pathological ag-
gregation in neuronal plaque and Lewy bodies, which are associated with Parkinson’s Disease and
Lewy Body Dementia, respectively12–15. Despite its medical significance, the normal function of
αS has been elusive. αS is a 14 kDa soluble protein that is abundantly present in the neuron
(several µM), particularly in the presynapse16,17. Not surprisingly, αS has been found to play roles
in various aspects of vesicle recycling18–21. Recently, αS has emerged as an important regulator for
SNARE-dependent vesicle fusion.
Sudhof and coworkers discovered that αS promotes SNARE complex formation via its in-
teraction with v-SNARE VAMP222. Consistent with these results, Lou et al. 2017 found in
an in vitro study that αS promotes vesicle docking23. However, the proposed positive role of
αS in SNARE-dependent membrane fusion appears to be at odds with the results from nearly
all overexpression studies. The overexpression studies show that αS leads to the impairment of
neurotransmission19,20,24,25. Although it was shown that overexpressed αS disturbs vesicle pools20,
its direct interference with the SNARE complex formation cannot be ruled out. Furthermore,
several in vitro studies have shown that excessive αS severely inhibits SNARE-dependent mem-
brane fusion26,27. Thus, the results raise the question if the αS function is acutely concentration-
dependent and, furthermore, if excessive αS is a cause of the impaired neurotransmission. If true,
this might have serious medical implications. Similarly, for Alzheimer’s disease, excessive but non-
aggregated amyloid β has been suspected for the impaired neurotransmission and early symptoms
of the disease28,29.
To sort out the discrepancy among the results, RK and BH used an in vitro single-vesicle-to-
supported bilayer merger assay30, in which, unlike the cellular environment, the precise variation of
αS concentration is possible. Moreover, this assay provides the opportunity to dissect the impact of
αS on individual vesicle fusion steps such as vesicle docking and bilayer merger along the membrane
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fusion pathway. The assay has proven effective in analyzing single bilayer merger events in a natural,
millisecond timescale between vesicle and a supported bilayer30.
Using this assay, RK and BH have found that αS enhances vesicle docking by a factor of 10 at
an excessive 20 µM concentration, which is as much as 4 times higher than normal cellular levels.
These results contradict the notion that excessive αS impairs vesicle fusion and neurotransmission,
which is previously supported by overexpression as well as the in vitro studies. Furthermore, the
detailed analysis reveals that the effect of αS on SNARE-dependent membrane fusion is largely on
vesicle docking with no significant changes in the dynamics of bilayer merger.
4.3 Results
4.3.1 Single Vesicle-to-Supported Bilayer Merger Assay
To investigate the effect of αS on SNARE-dependent vesicle fusion, RK and BH analyzed
the merger of single v-SNARE VAMP2-reconstituted vesicles (v-vesicles) to the supported bilayer
reconstituted with t-SNAREs syntaxin-1A and SNAP25 (t-bilayer) with TIRF microscopy (Figure
4.1A). Similar experimental platforms have been previously used by several groups to investigate
SNARE-dependent membrane fusion32–35. RK and BH adopted this method instead of the vesicle-
to-vesicle fusion method23,36 because the supported bilayer better mimics the planar geometry
of the plasma membrane. The planar t-bilayer rests on polyethylene glycol (PEG) supports to
maintain the membrane fluidity30,34. The v-vesicles are doped with 1 mol % lipid-dye DiI as a
reporter for the diffusion of phospholipid molecules from a v-vesicle onto the planar bilayer upon
the merging of lipid bilayers. Immediately after v-vesicles were flowed over the supported bilayer
in the microfluidic chambers, vesicle docking and bilayer merger events were filmed every 20 ms for
30 s. Individual docking and subsequent bilayer merger events could be resolved from each other.
When a vesicle is tethered to the surface, docking caused a sharp increase in fluorescence, but
when the bilayers merged, the lipids diffused in the two-dimensional (2-D) surface creating a steep
decline in fluorescence at the centroid (Figures 4.1B–D). The cumulative number of vesicle docking
events (Figure 4.1F) and the delay between docking and bilayer merger were recorded for further
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analysis of the kinetics (Figure 4.1G). From data collected from both RK and BH, we found that
about 40–60% of docked vesicles exhibit bilayer merger (Figures 4.1F–G). Of those events, nearly
70% showed instant bilayer merger (within the first 20 ms), while 30% were scattered over the 30
s recording time (Figure 4.1G).
4.3.2 αS Enhances Vesicle Docking in all Concentrations Studied up to 20 µM
Recombinant αS was expressed in E. coli as a GST-fusion protein and it was purified with
gel-filtration chromatography after cleavage from the GST-tag. SDS-PAGE gels and western blots
showed that the protein still had trace amounts of high molecular weight bands after one round of
gel filtration (Figure 4.2A). Thus, the sample was subjected to a subsequent round of gel filtration
to attain a higher purity. When this highly purified, twice filtered αS was included in the single-
vesicle assay, it enhanced SNARE-dependent vesicle docking events in a concentration-dependent
manner (Figure 4.2B). It promoted vesicle docking dramatically with as much as a 13 fold at 10
µM and 10 fold even at 20 µM. The analysis program to analyze the results was written by BH
and the subsequent data was analyzed by RK. The results were surprising and appear to contradict
previous results from overexpression studies20 and those from several in vitro studies26,27, where
20 µM αS almost completely abolished bilayer merger and subsequent fusion. RK and BH both
tested the SNARE dependence of the αS enhancement by removing the SNARE component on the
vesicles (VAMP2). Without VAMP2 membrane docking and merger was abolished. 10 µM αS did
not generate any events in the absence of VAMP2 demonstrating the SNARE dependence of αS
enhancement (Figure 4.2B).
RK and BH wondered if the discrepancy between the present and previous results stemmed
from the high molecular weight bands in under-purified samples. To test this, RK and BH used
αS from the 1st gel filtration, containing small amounts of high molecular weight bands, in our
bilayer merger assay. We observed a small enhancement in vesicle docking at lower concentrations.
However, there was a significant inhibition of vesicle docking at αS concentrations greater than 5
µM with vesicle docking and bilayer merger activity almost nonobservable at 20 µM (Figure 4.2C).
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This concentration-dependent variation is reminiscent of a previous in vitro study by Lou et al. 2017
using the single vesicle-to-vesicle fusion assay23. The drastic effect from the small amount of high
molecular weight bands from a single round of gel filtration could also explain why the enhancement
of the highly purified αS plateaued after 10 µM. A minute amount of the high molecular weight
bands could still be present in the highly purified αS, and thus negate the continued enhancement
of the non-aggregated αS.
Next, with the highly purified αS, I carried out a detailed analysis which includes the number of
bilayer merger events at various αS concentrations (Figure 4.3A), the percentage of docked vesicles
that merged (Figure 4.3B), the percentage of instant merging vesicles vs. delayed merging vesicles
(Figure 4.3C), and the kinetics of the time delay from docking until bilayer merger (Figures 4.3D–F).
Upon analysis of the number of bilayer merger events with and without αS, RK and BH found that
increasing the amount of αS led to an increase in the amount of bilayer merger, even at excessive
20 µM concentrations (Figure 4.3A). In order to dissect the specific role of αS, I investigated the
bilayer merger efficiency. The merger efficiency (Figure 4.3B) shows that although there is a small
decrease of the efficiency as αS increases, it seems that the variation is overall within experimental
errors. Thus, the data shows that αS does not significantly affect the bilayer merger efficiency,
revealing that the increase in bilayer merger events with αS is mainly due to its dramatic upstream
enhancement of vesicle docking.
Next, BH analyzed the time delay from docking until bilayer merger (Figure 4.3C). For all
αS concentrations studied, nearly 70% of all bilayer mergers happen within the first 20 ms after
docking. The rest (30%) are spread over the 30 s recording time. RK and BH did not observe any
significant changes on these results with αS. Further on, BH fit the cumulative merger events with a
double exponential to find the first-order time constants for both instant and delayed merger events
(Figure 4.3D). The time constant for instant merger varies between 2 and 5 ms (Figure 4.3E) while
the time constant for delayed merger varies between 100 and 200 ms (Figure 4.3F). Neither of the
time constants changes significantly with αS. Thus, the results show that αS has little effect on the
time delay from docking to bilayer merger.
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4.3.3 Vesicles Are Not Clustered Upon Docking Onto the t-bilayer Surface in the
Presence of αS
Previously, Diao et al. 2013 showed with a single vesicle-to-vesicle assay that non-aggregated
αS induces vesicle clustering and argued that vesicle clustering is the cause of the enhancement
of SNARE complex formation by αS37. To examine if vesicles are clustered upon docking on
the supported bilayer, BH measured the initial fluorescence intensities of all docking events. An
increase in the intensity would correlate to an increase in the number of vesicles involved in a
docking event. The intensity vs. population plot shows that the αS does not shift or broaden the
intensity distribution (Figure 4.4), indicating that αS-induced vesicle clustering does not play a
role in the enhancement of vesicle docking.
4.4 Discussion
There have been many attempts to elucidate the physiological role of normal, non-aggregated
αS. Studies with cultured neurons have observed that overexpression of αS impairs neurotransmitter
release19,20,24,25. Knockout studies in mice showed no early phenotypes, but had earlier onset of
neurological issues38–40. This leads to the notion that αS has the potential to be toxic at excessive
concentrations, but necessary at normal concentrations for some unknown reasons. Multiple in
vitro studies have been performed with contradicting observations. Some groups observe that αS
inhibits SNARE-dependent membrane fusion26,27, while others observed an enhancement23,41,42.
Previously, the Shin lab demonstrated in an in vitro single vesicle-vesicle fusion assay that αS has
a very narrow concentration window in which it enhances SNARE-dependent vesicle docking23.
Here, in order to better investigate αS’s role on SNARE-dependent membrane fusion, RK and BH
used a TIRF vesicle-to-supported bilayer merger assay. Unlike the vesicle-to-vesicle platform36, the
flatness of the t-bilayer mimics the target plasma membrane more accurately. This is a necessary
improvement to avoid potential artifacts stemming from the αS’s preferential binding to the curved
membrane26,43,44. With this assay employing the highly pure protein, RK and BH show that αS
enhances SNARE-dependent vesicle docking even at excessive concentrations.
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Although it may vary widely, the cellular concentration of αS is estimated to be roughly 5
µM45,46. Overexpression typically increases αS by a factor of 2 to 3. Thus, our data shows that
αS plays a positive role in vesicle-to-bilayer merger under overexpression conditions. Why does
overexpression of αS then impair neurotransmitter release? We speculate that soluble aggregates
of αS, although small in quantity, interfere with the SNARE function. In fact, it is shown that
soluble aggregates of αS can inhibit SNARE-dependent membrane fusion effectively even at a 100
nM monomer concentration47. Overexpression inevitably renders aggregation of αS over time.
The small increase of these high molecular weight bands is enough to negate any enhancement by
non-aggregated αS, which demonstrates their potency.
Our data shows that the promotive effect of αS on SNARE-dependent bilayer merger is mainly
through the enhancement of vesicle docking. Other than the number of vesicle docking, RK and
BH did not observe significant changes in the merger efficiency, the ratio of instant to delayed
merger events, or the kinetics of bilayer merger. However, it has been recently shown that αS plays
a role in accelerating fusion pore opening48. Because our assay uses a lipid probe that reports the
lipid dynamics, we are not able to test this mechanistic model on fusion pore dynamics, warranting
further investigation using the fluorescent content reporters.
Combining the present and previous work, two apparent tracks of the regulation of SNARE-
dependent membrane fusion by αS emerge (Figure 4.5). When αS is non-aggregated, it plays a
positive role in bilayer merger by promoting vesicle docking. Recently, Lou et al. 2017 proposed
a mechanistic model for this positive regulation23, envisioning that αS binds to VAMP2 using its
unstructured C-terminus. It interacts simultaneously with the target plasma membrane in trans
using its amphipathic N-terminal region, whereby aiding the recruitment of synaptic vesicles to the
plasma membrane. On the other hand, when aggregated, the multivalent oligomeric species could
bind to multiple VAMP2 on the vesicle, incapacitating its ability to interact with t-SNARE on the
plasma membrane47. As such, the bilayer merger would be severely inhibited.
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4.5 Conclusion
Overexpression of αS in vivo studies results in diminished neurotransmitter release in cultured
neurons. This supports the argument that in addition to the aggregates, excessive amount of non-
aggregated αS might be neurotoxic too. Our detailed analysis using in vitro single-vesicle bilayer
merger assay shows that αS is beneficial for SNARE-dependent vesicle fusion even at excessive
concentrations, but the apparent toxicity of αS might be mainly due to the presence of the ag-
gregated species. RK and BH observed enhancement of SNARE-dependent vesicle docking and
bilayer merger, even in extreme concentrations of pure αS, with 13 fold enhancement at 10 µM αS.
The vesicle-to-supported bilayer merger assay could help reveal how SNARE regulators affect each
step in SNARE-dependent membrane fusion and thereby advance our understanding of how these
regulators affect neurotransmission.
4.6 Materials and Methods
4.6.1 Plasmid Constructs and Site-Directed Mutagenesis
DNA sequences encoding syntaxin-1A (amino acids 1-288 with three native cysteines replaced
by alanines), VAMP2 (amino acids 1-116 with C103 replaced by alanine), SNAP-25 (amino acids 1-
206 with four native cysteines replaced by alanines), and αS (amino acids 1-140) were inserted into
a pGEX-KG vector as N-terminal glutathione S-transferase (GST) fusion proteins. DNA sequences
were confirmed by the Iowa State University DNA sequencing facility.
4.6.2 Protein Purification
All N-terminal GST recombinant neuronal SNARE proteins and αS were expressed in Es-
cherichia coli BL21 (DE3) cells. SNARE proteins were purified in the same manner as previously
detailed31. The αS was grown at 37◦C in LB (Luria–Bertani) medium with 100 /mug/mL ampicillin
until the absorbance at 600 nm reached 0.6–0.8. The cells were induced to express overnight by
adding IPTG (isopropyl β-D-thiogalactopyranoside, 0.3 mM final concentration) at 16◦C. Proteins
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were purified using glutathioneagarose chromatography. Cell pellets were resuspended in 15 ml of
high salt PBS (HSPBS) (497 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 6.5),
with final concentrations of 1 mM AEBSF [4-(2-aminoethyl)benzenesulfonyl fluoride], 2 mM DTT
(dithiothreitol), and 20% N-lauroylsarcosine. Cells were lysed by homogenization and centrifuged
at 25,000 x g for 30 min at 4◦C. The supernatant was mixed with 1 ml of glutathione-agarose beads
in HSPBS by nutation at 4◦C for 2 h. After washing the protein with HSPBS, the protein was
cleaved by thrombin (30 U) at 4◦C overnight. For all the experiments, I performed the purication
of the proteins up to this step, subsequent steps were performed by BH. The protein was eluted,
concentrated to ∼1 ml, and then loaded on to an AKTA FPLC with a GE Superdex Increase 200
10/300 column for size-exclusion chromatography exchanging αS into PBS (137 mM NaCl, 2.7 mM
KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4). Samples from individual fractions were run on
a 15% SDS-PAGE gel to identify fractions that lacked high molecular weight bands (Supplementary
Figure S4.6). These fractions were then combined, concentrated to ∼1 mL, and subjected to the
FPLC again. Fractions were again checked for any high molecular weight bands. Those without
were combined, concentrated, had glycerol added to a final concentration of 15%, and then stored
at -80◦C (Supplementary Figure S4.6). αS was used within 2 weeks of purification. Aggregation
into high molecular weight bands within this time frame was negligible (Supplementary Figure
S4.7).
4.6.3 Western Blotting
The western blotting was performed by BH. Alpha-synuclein was run on a 12% SDS-PAGE.
SDS was rinsed from the gel by microwaving the gel in diH2O (deionized water) for 40 s three times
with each time exchanging the diH2O. An Invitrogen iBlotTM two Dry Blotting System was used to
transfer to a PVDF membrane. The membrane was then blocked overnight with 5% (w/v) non-fat
dry milk in TBST (20 mM Tris–HCl, pH 7.4, 137 mM NaCl, 2.7 mM NaCl, 0.1% Tween-20) at
4◦C. The membrane was rinsed with TBST twice, then incubated in 5% (w/v) non-fat dry milk in
TBST with 1 /mug/mL alpha Synuclein Monoclonal Antibody (Syn 211) (Invitrogen 32-8100) for
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2 h at room temperature. Then, the membrane was rinsed three times with TBST and incubated
with 5% (w/v) non-fat dry milk in TBST with Goat Anti-Mouse IgG (H + L)-HRP Conjugate
(Bio-RAD 1706516) for 45 min at room temperature. The membrane was then washed with TBST
three times and reacted with Pierce ECL Western Blotting Substrate (Thermo Fisher 32106) for 1
min. The western blot was visualized with a ChemiDOC system (Bio-Rad).
4.6.4 Membrane Reconstitution
The lipids were generated and proteins were reconstituted by both RK and BH on mul-
tiple occasions. The t-bilayer was made using a mixture of POPC (1-palmitoyl-2-dioleoyl-sn-
glycero-3-phosphatidylcholine), DOPS (1,2-dioleoyl-sn-glycero-3-phosphatidylserine), PIP2 (phos-
phatidylinositol 4,5-bisphosphate from porcine brain), and PEG2000 (1,2-dipalmitoyl-sn-glycero-
3-phosphoethanolamineN-[methoxy(polyethylene glycol)-2000]) in chloroform at a molar ratio of
78:15:2:5. The v-lipid was made using a mixture of POPC, DOPS, cholesterol, and DiI (1, 10-
Dioctadecyl-3, 3, 30, 30-tetramethylindocarbocyanine perchlorate) in chloroform at a molar ratio
of 54:5:40:1. Both lipid mixtures were first dried under an air stream, then dried in a vacuum
overnight. The t-bilayer lipid was resuspended in HEPES (25 mM HEPES/KOH, 150 mM KCl,
pH 7.4) + 1% OG (Octyl-beta-Glucoside). The v-lipid was resuspended in HEPES and then un-
derwent 10 flash freeze-thaw cycles moving from liquid nitrogen to boiling water. Protein-free
large unilamellar vesicles (∼100 nm in diameter) were prepared by extrusion through polycarbon-
ate filters making v-liposomes. For the t-bilayer syntaxin-1A and SNAP-25 in a molar ratio of
1:1.5, were premixed, and the mixture was left at room temperature for 0.5 h to form the t-binary
complex before the reconstitution. The t-bilayer lipid was added to the t-binary complex so that
the lipid to t-binary complex ratio was 2000:1. Then, the liposome/protein mixture was diluted
by adding three times the volume of the protein lipid mixture of HEPES. To generate functional
v-vesicles, v-liposomes were mixed with the VAMP2 at a lipid to VAMP2 ratio of 200:1. Then
the liposome/protein mixture was diluted by adding three times the volume of the protein lipid
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mixture using HEPES. Both liposome/protein mixtures were dialyzed overnight at 4◦C in 2 L of
HEPES containing Biobeads SM-2 Resin.
4.6.5 Vesicle-to-Supported Bilayer Merger TIRF Assay
This assay was performed by both RK and BH side by side using two slides per experimental
trial. A quartz slide and glass cover slip were subjected to piranha cleaning by boiling them in a
1:1 mixture of concentrated sulfuric acid and 30% hydrogen peroxide for 15 min. The slides were
rinsed with diH2O and placed in a cleaning sonicator for 30 min to remove residual acid. The
slides were dried and prepared with the double-sided tape and the cover slip to generate several
separate microfluidic chambers. The chambers were then filled with t-bilayer that was prepared
from the overnight dialysis. The t-bilayer was allowed to form on the quartz surface for 1 h at room
temperature. The excess liposomes/protein mixture was washed out with HEPES and replaced
with an indicated concentration of αS in HEPES. The αS was incubated with t-bilayer for 1 h
while heating at 37◦C. The quartz slide with the microfluidic chambers was then placed on the
imaging stand of our microscope, which regulated the temperature of the slide to 37◦C. Imaging oil
was put on the prism of our prism-type total internal reflection fluorescence (TIRF) microscope,
and then the prism was lowered onto the quartz slide. The incident angle of the exciting laser (532
nm) was adjusted and we initiated real-time movie acquisition with an imaging area of 55 x 110
/mum using 20 ms time resolution. We then gently injected the v-vesicles from dialysis with an
indicated concentration of αS into the microfluidic chamber. The injection pump was promptly
stopped after injection to prevent vesicle merger events from the flow effect (Figure 4.1A). We
collected 60 s movies for each microfluidic chamber and analyzed the final 30 s for docking and
merger events using our custom-built analysis software.
4.6.6 Data Analysis
Using a home-made analysis software written in MATLABR 2014 (b) by BH, we both were
able to monitor the fluorescence intensity of DiI from the v-vesicles in order to determine docking
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and subsequent merger events. Each recording was analyzed by me frame by frame based on
both visual determination (Figure 4.1B) and fluorescence trace pattern analysis (Figures 4.1C–E).
Both criteria had to be met for an event to be counted. All three events are initiated by both
a vesicle becoming immobilized on the surface and a sharp increase in the fluorescence. Instant
merger events were then defined as lipid diffusion happening on the very next frame as well as an
immediate sharp fluorescence decrease (Figure 4.1D). Delayed merger events were defined by lipid
diffusion being observed several frames after docking, with a secondary fluorescence spike upon lipid
merger, followed by an immediate, sharp decrease (Figure 4.1E). Docking only events did not show
lipid diffusion before the fluorescence intensity faded gradually over time due to photobleaching
(Figure 4.1F). From the analysis, I counted individual immobilized v-vesicles, vesicles showing lipid
merger, and the delay time between docking and lipid merger within a movie clip. At least three
independent recordings were analyzed to obtain the statistical significance for each data set.
4.6.7 Exponential Curve Fitting
This exponential curve fitting was done by BH. All membrane merging data was combined for
each concentration of αS. The membrane merging events were cumulatively plotted by binning
events by the maximal delay. For example, if the event was seen to fuse in a single frame, then it
was binned in the 0–20 ms bin and plotted as an event at 20 ms. MATLABR 2014 (b) curve fitting
toolboxTM 3.5 was used to fit F(x) = A(1-exp((-x)/B))+C(1-exp((-x)/D)+E to the cumulative
plot allowing A, B, C, D, and E to be optimized using Non-linear Least Squares with Bisquare for
robustness. Standard deviations were calculated by taking all events for a concentration of αS and
assigning them randomly to a subgroup, fitting each subgroup, and comparing their best fitting
parameters to the global fit to the total data.
4.7 Author Contribution
This project resulted from an equal contribution from RK and BH. I purified the proteins nec-
essary for the single-molecule TIRF assay up to the stage of GST cleavage. The FPLC purification
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and varication was done by BH. RK and BH used the purified protein in the single-molecule TIRF
assay and collected two sets of data from two slides made individually. The data and figure gen-
eration was performed by RK. BH wrote the analysis program and optimized for our needs. The
interpretation of the data and writing of the manuscript was done by RK and BH.
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Figure 4.1 Single vesicle-to-supported bilayer merger assay distinguishes vesicle docking
from bilayer merger in real time.
(A) Schematic diagram of the single vesicle-to-supported bilayer merger assay. V-vesicles are
labeled with 1 mol % lipid-dye DiI. The t-bilayer is stabilized by a PEG (polyethylene glycol)
cushion between the bilayer and the quartz slide. When v-vesicles dock onto the t-bilayer through
SNARE zippering, the TIRF laser excites the fluorescent dye allowing the individual v-vesicle to
be visualized. (B) Lipid diffusion on the bilayer surface due to bilayer merger. The large box
contains a raw image of the docked and merging vesicles. The small box contains a zoomed image
of lipid diffusion event. (C) Representative trace of the instant merger. (D) Representative trace
of the delayed merger. (E) Representative trace of docking only. The fluorescence decay due to
photo-bleaching is at least 5 times slower than the decrease due to lipid diffusion. Further
classification of instant merger, delayed merger, and docking only events are defined in the
Materials and Methods section. (F) Representative cumulative plot of docking events occurring
within a single viewing area for 30 s. The black line indicates cumulative docking events without
αS. The red line indicates those with twice purified αS at 10 µM. (G) Representative scatter plot
of the delay from docking to bilayer merger. Bilayer merger events that occur within the first 20
ms after docking are classified as instant merger, whereas merger events that occur later are
classified as delayed merger. The data in figures 1C-G was collected equally by RK and BH. The














































































Figure 4.2 Non-aggregated αS enhances vesicle docking activity even at excessive concen-
trations.
(A)SDS-PAGE and western blot analysis of purified recombinant αS. A 12% SDS-PAGE gel
containing αS through the two rounds of gel filtration: Lane 1 contains αS after the 1st round of
gel filtration. Lane 2 contains αS after the 2nd round of gel filtration (left panel). A western blot
of αS through the two rounds of gel filtration (right panel). The lane order is the same as
SDS-PAGE. Bracket encloses higher molecular weight αS bands observed only in the sample from
a single round of gel filtration. The protein purification up to the GST cleavage and verification
with SDS-page gel was done by me. The FPLC purification and western blot was performed by
BH. (B) Analysis of vesicle docking with twice purified αS (lane 2 in A). The number of docking
events for each αS concentration is normalized relative to that without αS. The dashed line
represents the vesicle docking activity of SNAREs without αS. Studies without VAMP2 were
done by flowing v-liposomes without VAMP2 reconstituted in them along with 10 µM αS over the
supported t-bilayer. No events were observed. In total 3,148 docking events from 82 independent
measurements are analyzed. (C) Analysis of vesicle docking with one-time purified αS (lane 1 in
A). The number of docking events from each αS concentration is normalized with respect to those
without αS. The dashed line represents the docking activity of SNAREs without αS. Studies
without VAMP2 were done in the same way as in B. A total of 6,249 vesicle docking events from
65 independent measurements are analyzed. The data in figures 2B-C was collected equally by
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Figure 4.3 Effect of αS on SNARE-dependent membrane fusion is mainly on docking with
little influence on the dynamics of bilayer merger.
(A) Analysis of the bilayer merger dynamics with twice purified αS. The number of merger events
at various αS concentrations are normalized with respect to events without αS. The dashed line
represents the membrane merger activity of SNAREs without αS. (B) Analysis of the bilayer
merger efficiency of twice purified αS. The efficiency is calculated as the number of merger events
divided by the number of docking events. (C) Instant merger vs. delayed merger. Instant merger
events display lipid-diffusion in under 20 ms and delayed merger events are any that take longer
than 20 ms.. (D) Representative cumulative plot of bilayer merger events with twice purified αS.
The red line is the double exponential fit to the data of merger events. (E) Plot of time constants
for instant merger events. (F) Plot of time constants for delayed merger events. The total of
1,247 merger events from 82 independent recording were included in the fitting analysis. The data
in figures 3A-F was collected equally by RK and BH. The data was analyzed by RK using an
























Figure 4.4 αS does not promote clustering of vesicles on the supported bilayer.
Distribution of initial fluorescence intensities of individual docking events at various
concentrations of twice purified αS. The maximum population for each concentration is
normalized to 1 for comparison. The initial intensities of 2,194 docking events from 58
independent recordings are analyzed. The data was collected equally by RK and BH. The data











Figure 4.5 A proposed mechanistic model for enhancement and inhibition of SNARE-de-
pendent vesicle fusion by αS.
The enhancement model involves monomeric αS acting as a cross-bridge to facilitate vesicle
docking to the phospholipid bilayer. αS has a N-terminal membrane binding region that binds to
the phospholipid bilayer and the C-terminal region that interacts with VAMP223. The inhibition
model involves oligomeric, multivalent αS interacting and clustering VAMP2, thus preventing it









































































Figure 4.6 Two round gel filtration of αS.
(A) Chromatogram from the 1st round of gel filtration. After one round of gel filtration, αS elutes
as two overlapping peaks between fractions 7–14. The UV absorbance value has been normalized
with respect to the maximum peak intensity. (B) SDS-PAGE gel after the 1st round of gel
filtration. The fraction numbers indicated on the SDS-PAGE correspond to the fractions shown in
part (A). Fractions 7–10 display a high molecular weight bands which correlates to the first peak
in the chromatogram. Fractions 11–14, indicated by arrows, were combined, concentrated, and
subjected to another round of gel filtration. (C) Chromatogram from the 2nd round of gel
filtration. After two rounds of gel filtration, αS elutes as a single peak between fractions 10–14.
(D) SDS-PAGE of the 2nd round of gel filtration. Fractions 12–14 display a molecular weight
bands consistent with αS which correlates to the single peak in the chromatogram. A conservative
approach was used and fractions containing an arrow underneath were combined, concentrated



















Figure 4.7 SDS-PAGE of purified αS before and after storage at -80◦C.
(A) SDS-PAGE gel of αS immediately after two rounds of gel filtration before storing at -80◦C.
(B) SDS-PAGE gel of the same αS after 2 weeks of storage at -80◦C. The was performed by BH.
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CHAPTER 5. MEMBRANE BINDING OF α-SYNUCLEIN STIMULATES
EXPANSION OF THE SNARE-DEPENDENT FUSION PORE
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SNARE-dependent membrane fusion is essential for neurotransmitter release at the synapse.
Recently, α-synuclein has emerged as an important regulator for membrane fusion. Misfolded α-
synuclein oligomers are potent fusion inhibitors. However, the function of normal α-synuclein has
been elusive. Here, we use the single vesicle-to-supported bilayer fusion assay to dissect the role of
α-synuclein in membrane fusion. The assay employs 10 kD Rhodamine B-dextran as the content
probe that can detect fusion pores larger than ∼6 nm. We find that the SNARE complex alone
is inefficient at dilating fusion pores. However, α-synuclein dramatically increases the probability
as well as the duration of large pores. When the SNARE-interacting C-terminal region of α-
synuclein was truncated, the mutant behaves the same as the wild-type. However, the double
proline mutants compromising membrane-binding show significantly reduced effects on fusion pore
expansion. Thus, our results suggest that α-synuclein stimulates fusion pore expansion specifically
through its membrane binding.
5.2 Introduction
Communication between neurons, which underlies cognition, memory, and motor movement, is
built upon neurotransmitter release at the synapse. In the neuron, cargo vesicles undergo membrane
fusion with the plasma membrane, which releases the neurotransmitters to the synaptic cleft. It
is established that the widely-conserved SNARE (soluble N-ethylmaleimide-sensitive factor attach-
ment protein receptor) complex is the minimal machinery that drives membrane fusion1,2. SNARE
motifs from vesicle v-SNARE VAMP2 (or synaptobrevin 2) and those from target plasma membrane
t-SNAREs syntaxin-1A and SNAP-25 form a highly stable parallel coiled-coil3,4. There is evidence
that the SNARE complex zippers from the membrane-distal region to the membrane-proximal
region, culminating the folding energy towards apposition and merger of two membranes5–7.
The membrane fusion process transits through distinct multiple stages (Fig. 5.1). Hemifusion,
in which outer leaflets of two bilayers are merged but inner leaflets are not8,9, is followed by
formation of a small aqueous fusion pore through which neurotransmitters are allowed to pass10,11.
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The small pore then dilates to a large pore that could ultimately lead to a complete merger of two
membranes into a single bilayer12. Alternatively, after brief release, the fusion pore could close
and the vesicle might then disengage from the plasma membrane without complete fusion, termed
kiss-and-run13. It is unknown what protein factors control the bias between two pathways.
α-synuclein (αS) is one of the most prevalent presynaptic proteins. But, when misfolded or
aggregated, those aberrant forms are known to have close ties to the Parkinson’s disease and
Lewy body dementia. Despite its abundance, its regular functions in the neuron have been elusive.
Recently, there has been evidence that αS controls the size of the vesicle pool14, vesicle clustering15,
as well as vesicle docking to the plasma membrane16. In addition, αS may stabilize SNARE
complexes by interacting with VAMP217.
Recently, Edwards and coworkers have proposed that αS plays a role in the dilation of the fusion
pore, potentially biasing vesicle recycling towards the complete fusion pathway18. They found that
overexpressed αS promotes the release of the large cargo in chromaffin cells. However, it is unknown
if αS also functions as a fusion pore dilator in the neuron and if it is the result of direct interaction
with SNAREs or an indirect consequence of a multiprotein pathway.
On a molecular level, there are two well-known interactions for αS. The first is the interaction
between its acidic C-terminal region and vesicle-attached VAMP219. This specific interaction has
been shown to be responsible for vesicle clustering15, vesicle docking16 as well as inhibition of vesicle
fusion20. The second is the membrane binding due to its affinity of the amphipathic N-terminal
region toward negatively charged lipids21 Despite extensive investigations, the physiological function
of αS’s membrane binding is not fully understood22.
In this work, we monitor the real-time dynamics of the fusion pore induced exclusively by
SNARE proteins with the in vitro single vesicle-to-supported bilayer fusion assay23–26. With this
well-defined system, we intend to pinpoint the exact role that αS plays in the fusion pore dynamics.
By encapsulating a fluorescent polymer probe of approximately 6 nm in diameter27, we are able
to observe the transient opening and contraction of the large fusion pore. We find that SNAREs
alone are inefficient at generating a large fusion pore. When we include αS, however, we observe a
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dramatic increase in the number of vesicles that have the ability to open the large pore. Also, we
observe a significant increase of the duration of the large pore. However, when the double proline
mutants (A11P/V70P and T44P/A89P) of αS with much reduced membrane binding were used,
the stimulating effects on fusion pore expansion were significantly diminished. In contrast, the
truncation mutant in which VAMP2-interacting C-terminal region is deleted (αS 1-95), behaved
the same as the wild-type.
5.3 Results
5.3.1 Single vesicle-to-supported bilayer fusion assay to monitor a large fusion pore
To probe the SNARE-induced large fusion pore, we monitor single vesicle-to-supported bilayer
fusion utilizing total internal reflection fluorescence microscopy (TIRFM) (Fig. 5.2a). The sup-
ported bilayer contains 5 mole% polyethylene glycol (PEG)-PE that creates a PEG-pillared aqueous
gap between the bilayer and the quartz support through which a fluorescent reporter could diffuse.
We use Rhodamine B conjugated to 10 kD dextran (RB-dextran) as the fluorescent reporter for the
fusion pore. The rationale for using RB-dextran is two-fold. Firstly, the hydrodynamic diameter of
the molecules is estimated to be ∼6 nm. Thus, unlike small fluorescent probes, its 2D diffusion in
the aqueous gap is predicted to be sufficiently slow to be readily visible with TIRFM of millisecond
time resolution. Secondly, RB-dextran is allowed to escape from the vesicle when the fusion pore
opens larger than ∼6 nm in diameter, enabling the detection of a large fusion pore.
The supported bilayer is prepared by spontaneous fusion of proteoliposomes, reconstituted with
t-SNAREs (lipid-to-protein ratio (L/P) = 2000), onto a clean, hydroxylated quartz surface in
the flow cell. The quality and the homogeneity of the supported bilayer are visually inspected
under a microscope with a small amount (0.5 ppm) of the lipid dye DiD (1,1’-Dioctadecyl-3,3,3’,3’-
Tetramethylindodicarbocyanine). Separately, v-SNAREs are reconstituted into liposomes that en-
capsulate RB-dextran as the internal content.
To monitor the large fusion pore, the v-vesicles are injected into the flow cell containing the
pre-formed supported bilayer. The formation of the SNARE complexes mediates vesicle docking
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and fusion. When a v-vesicle docks to the bilayer, a fluorescent spot appears on the imaging surface
(red spike in Fig. 5.2b). Subsequently, if a fusion pore greater than 6 nm in diameter is induced, we
observe 2D diffusion of fluorophores as RB-dextran is dispersed underneath the supported bilayer
(green trace in Fig. 5.2b). The large pore often contracts prior to complete fusion. Pore contraction
results in a solid fluorescence spot with a reduced intensity that gradually fades to dark (blue trace
in Fig. 5.2b). The slow decrease of fluorescence in this phase most likely indicates the slow leakage
of the polymer content via a small fusion pore. In fact, Chapman and coworkers have recently
shown that SNARE complexes alone can sustain prolonged opening of a small fusion pore28.
Surprisingly, in the time trace, we observe that content release causes the initial increase and
then, the subsequent decrease of the fluorescence intensity (green trace in Fig. 5.2b). Since the
entrapped fluorophore concentration (90 µM) is lower than the critical concentration for self-
dequenching, we rule out the possibility that the initial increase of fluorescence is due to self-
dequenching. A likely scenario for the initial increase of the fluorescence intensity is that the
internal content of the vesicle moves into the region of the stronger evanescent wave during forma-
tion of the large pore (Fig. 5.2c). The same phenomenon was observed by Tamm and coworkers
in fusion of chromaffin cells to the supported bilayer and they interpreted the data similarly26. In
such a case, the larger the size of the fusion pore, the more the vesicle would collapse to the surface,
and the higher the fluorescence intensity increase in the initial phase would be. Thus, the increase
of the fluorescence intensity at the beginning is likely to reflect the size of the fusion pore.
As controls, to confirm that content release is SNARE-dependent, individual SNARE proteins
are omitted or replaced with a disabled mutant in separate assays (Fig. 5.2d). The v-SNARE
dependence is tested using v-vesicles without VAMP2. When these vesicles are flowed over the
bilayer, there are virtually no content release events. The t-SNARE dependence is evaluated using
a SNAP-25 truncation mutant, SNAP-25E that is derived from the product of Botulinum toxin E
cleavage that removes 26 residues from the C-terminal SNARE motif. SNAP-25E, which has been
shown to impair vesicle docking29, supports no content release events. In both controls, there are
non-release events displaying vesicles that transiently dwell on the bilayer, without content release,
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followed by disengagement from the membrane (Fig. 5.2e). Events with such a fluorescent trace
pattern are excluded in the analysis.
5.3.2 SNAREs are inefficient at driving formation of the fusion pore larger than 6
nm
With SNAREs alone, a majority of the vesicles that dock to the surface of the bilayer via
SNARE zippering do not open a large pore. Out of the 285 events analyzed, 177 vesicles (62%)
do not show a sharp change of fluorescence nor 2D diffusion of fluorophores, indicating that the
large fusion pore was not formed. A prototypical fluorescence time trace representing this group
shows a spike in fluorescence due to docking, but it is followed by a slow decay of fluorescence to
the baseline over several seconds (Fig. 5.3a left).
A minor population was able to open the large pore briefly before contracting. This led to a
trace with an initial sharp increase and decrease of fluorescence prior to the slow leakage phase (Fig.
5.3a right). More precisely, 108 out of 285 (38%) vesicles analyzed show the sharp increase-decrease
of fluorescence and concurrent 2D diffusion of the fluorophores, reminiscent of the large fusion pore
(Fig. 5.3b). We also note that for a small percentage of the docked vesicles (5%), we observe two
discrete release events from a single docked vesicle. Thus, with SNAREs only, the probability of
the large fusion pore for a single docked vesicle is 38%, indicating that SNARE complex alone is
not an efficient driver of fusion pore expansion.
Besides the probability, other important parameters such as the duration and the qualitative
pore size can be estimated from the data. For the majority of large pore events, the large pore
contracts after the partial release, rarely reaching the full release. The duration of the large fusion
pore is defined as the time lapse of the green trace in Fig. 5.2b. The duration distributes between
0.02 s to 1.00 s with an average of 0.28 ± 0.18 s (Fig. 5.3c). On the other hand, the intensity increase
due to the flattening of the vesicle during large pore formation provides qualitative estimation of
the fusion pore size. The fluorescence intensity increases as much as 10 times with the median at
3 times (Fig. 5.3d), indicating significant flattening of the vesicle during the large pore event.
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It was previously shown that synaptotagmin-1 promotes dilation of the fusion pore30. Thus,
as a positive control, we added synaptotagmin-1 together with 500 µM Ca2+ concentration25. In
contrast to the case with SNAREs only, most vesicles show the full content release in a short time
span (∼0.02 s) producing a sharply spiked time trace (Fig. 5.3e). Thus, the results show that
synaptotagmin-1 with Ca2+ is a major stimulator for fusion pore dilation, consistent with previous
findings30,31.
5.3.3 αS promotes the probability, the duration, but not the size of the large fusion
pore
The vesicle-to-supported bilayer fusion assay employing a large polymer cargo provides an
opportunity to dissect the effect of the fusion modulators on the formation of the large fusion pore.
In Fig. 3, we demonstrate that the analysis of individual single vesicle fusion can yield probability,
duration, and relative size of the large fusion pore. To uncover the effect of αS on the formation of
SNARE-induced large pore, we included 5 µM αS, a typical cellular concentration, in our membrane
fusion assay32.
Firstly, out of 691 events analyzed, we found that αS drastically increases the probability of a
docked vesicle to form a large fusion pore. As much as 97% of docked vesicles showed the release
of RB-dextran, which is in sharp contrast with 38% for SNAREs only (Fig. 5.4a). However,
even in the presence αS, vesicles struggled to reach complete release through a large pore prior to
contraction. Secondly, with αS, the duration of the large pore is 1.15 ± 0.67 s on average, which
is an increase by about factors of 4 compared with the average duration with SNAREs only (Fig.
5.4b). Thirdly, we found that with αS, there is no further increase of the fluorescence intensity at
the initial phase of formation of the large fusion pore, indicating that sizes of the large fusion pore
remain approximately the same as those of SNAREs only (Fig. 5.4c). This resulted in αS displaying
a trace with a longer release phase than the trace of SNAREs alone (Fig. 5.4d). Thus, the results
show that αS increases the probability and the duration of the large fusion pore significantly, while
the size of the large fusion pore is largely unaffected.
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5.3.4 The SNARE interaction with αS does not affect fusion pore expansion
Structurally, αS is composed of distinct two parts, the membrane-binding amphipathic region
of N-terminal 100 residues and the acidic C-terminal region of 40 residues. The soluble C-terminal
region may be functionally important because it interacts with the N-terminal region of v-SNARE,
VAMP2. Lou et al. have shown that αS can cross-bridge a vesicle to the lipid bilayer by utilizing
these two interactions16. It is unclear if such cross-bridging can affect the fusion pore. To test this
idea, we generated the truncation mutant αS 1-95 by removing the final 45 amino acids from the
C-terminal of αS16,33.
This time, we used 200 nM for both wild-type αS and αS 1-95 due to the aggregation of αS 1-95
at the µM concentration range under our experimental conditions. Out of 403 events analyzed, we
found that the probability of the large fusion pore for αS 1-95 is similar to that for wild-type αS
(99% vs. 97%, respectively) (Fig. 5.5a). However, the average duration of the large pore for αS
1-95 is slightly shorter than that for wild-type αS (0.86 ± 0.50 s vs 1.15 ± 0.67 s, respectively)
(Fig. 5.5b). With αS 1-95, the increase of the fluorescence intensity at the initial phase of large
pore formation was somewhat less (2.86 ± 1.53) than the increase for the wild-type (3.38 ± 2.20)
(Fig. 5.5c). Thus, although there are some minor variations, our results show that the C-terminal
of αS and possibly, its interaction with VAMP2 is not much to do with the stimulation of the large
fusion pore.
5.3.5 Membrane binding of αS plays a role in stimulating fusion pore expansion
After learning that the interaction between αS and v-SNARE VAMP2 has minimal effects on
the parameters of fusion pore expansion, we asked if membrane binding of αS is the factor that
governs its stimulatory role in fusion pore expansion. Recently, Sudhof and coworkers isolated and
characterized double proline mutants of αS A11P/V70P and T44P/A89P whose membrane binding
activity is significantly impaired34.
In parallel to their impaired membrane-binding activity, both double proline mutants showed
significantly reduced stimulation of fusion pore expansion compared to that by the wild-type. In
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the presence of the mutants, the probability to open a large pore reaches only 50%, which is slightly
higher than that of SNAREs only, but much lower than 97% in the presence of wild-type αS (Fig.
5.6a). Similarly, the durations of the large fusion pore are longer than those with SNAREs only, but
shorter than those in the presence of the wild-type (Fig. 5.6b). Interestingly, it appears that the
rank order of the durations follows the rank order of the membrane affinity33, where the wild-type
is the first, T44P/A89 the second, and A11P/V70P the third for the both parameters. There was
no significant different in pore sizes between the wild-type and the mutations (Fig. 5.6c). Thus,
our results show that membrane binding of αS is the major factor that determines its activity of
stimulating fusion pore expansion.
5.3.6 Familial mutations A30P and A53T of αS moderately reduce the duration of
the large fusion pore
Studies of families with a history of Parkinson’s disease have resulted in the identification of
several familial mutations (αS A30P, E46K, and A53T) involved in early-onset forms of the disease.
Of those mutations, Edwards and coworkers have shown that A30P and A53T abolish promotion
of large cargo release by αS in chromaffin cells18.
To test if their findings are applicable for neuronal SNAREs, we examined three αS point mu-
tants with our single vesicle-to-supported bilayer assay. When compared to wild-type αS, all three
mutants have nearly identical capacities to increase the probability of large fusion pore formation
with probabilities > 90% (Fig. 5.7a). Interestingly, the duration of the large pore is somewhat
reduced to 0.61 ± 0.20 s for A30P and 0.69 ± 0.37 s for A53T compared to 1.15 ± 0.67 s for the
wild-type (Fig. 5.7b). Meanwhile, the duration for E46K is 1.05 ± 0.42 s, which is similar to that
for the wild-type within experimental uncertainty. For the increase of the fluorescence intensity at
the initial phase of the release, all familial mutants and the wild-type are statistically similar to
each other (Fig. 5.7c). Thus, the results suggest that for all αS familial mutations, the fusion pore
can grow as large as the size with the wild-type, but for A30P and A53T, the enlarged pore is not
as stable as that of the wild-type.
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5.4 Discussion
In this work, we have found, using an in vitro single vesicle fusion assay that αS has the capacity
to promote the formation of the large fusion pore in SNARE-dependent membrane fusion. Our
results are consistent with the findings by Edwards and coworkers18, that αS enhances the release
of a large protein cargo in chromaffin cells. For neuronal SNAREs, our data shows that αS increases
the probability of individual vesicles to advance to the large fusion pore (diameter larger than 6
nm). Moreover, our results show that the duration of the large fusion pore is also increased by
αS significantly. Consistently in neurons, Edwards and coworkers have found that αS delays the
closing of the fusion pore for the release of small neurotransmitter, therefore, most likely the small
fusion pore. Thus, the results together support the conclusion that αS has the tendency to keep
the fusion pore open longer than it is without αS, regardless of the size of the fusion pore.
Our results show that SNARE complex alone is only capable of expanding the fusion pore larger
than 6 nm in diameter for less than 40% of the docked vesicles. More than 60% of them are not able
to reach a pore size sufficiently large to allow release of 6 nm-diameter RB-dextran. Interestingly,
we find that the SNARE-induced large pore is transient. In the presence of αS, the probability of
large fusion pore formation is increased to nearly 100%.
Regardless of the presence of αS, after some release, the fusion pore contracts back to a very
slow release state, which is most likely a small pore stage. Such incomplete dilation leaves residual
RB-dextran in the vesicle. This suggests that although SNARE complexes can generate a transient
large fusion pore, they are not fully sufficient to drive the complete dilation of the fusion pore. In
sharp contrast, fusion pore expansion is fast and ends up with complete decantation of the content
in the presence of synaptotagmin-1 and Ca2+. Thus, we speculate that synaptotagmin-1 and Ca2+
are the determining factors that drive fusion pore expansion into completion.
We speculate that the stimulating effects of synaptotagmin-1 and Ca2+ and that of αS are
additive because synaptotagmin-1 and αS would not likely compete with each other for membrane
binding. Ideally, this prediction could be tested with a similar in vitro vesicle fusion assay to
the current one, but with a faster time resolution. The current method is limited with the time
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resolution of 20 msec, which is too slow to resolve the kinetics of fusion pore expansion in the
presence of synaptotagmin-1 and Ca2+.
On a molecular level, αS is known for the interaction with v-SNARE VAMP2 as well as its
interaction with the negatively charged membrane. The former is mediated by the binding between
the C-terminal end of αS and the N-terminal region of VAMP2. However, our results show that
this specific interaction has little to do with the probability, the duration, and the size of the
large fusion pore. When the VAMP2-binding C-terminal region of αS was eliminated the three
parameters remain virtually the same as that of the wild-type. Alternatively, the latter is mediated
by the affinity of the N-terminal amphipathic region to the acidic lipids. Our data unambiguously
finds that αS’s membrane-binding property plays a major role in fusion pore dilation. We speculate
that αS binds to the membrane and adapts to the diverse architecture of the fusion pore, which
stabilizes the membrane curvature35.
In chromaffin cells, Edwards and coworkers found that the familial mutations A30P and A53T
abolish the ability of αS to promote large cargo release. Intriguingly, we find that, although the
differences are small, these same familial mutations are not as efficient as the wild-type in providing
the stability of the enlarged fusion pore (Fig. 5.7b). However, it is not clear if such a small effect
is relevant to the early onset of the Parkinson’s disease, warranting further investigation.
In summary, elucidating the mechanism by which αS regulates SNARE-dependent membrane
fusion is of great general interest. In this work, using the in vitro single vesicle-to-supported
bilayer fusion assay employing 10 kD RB-dextran, we demonstrate that the SNARE complex could
drive the enlargement of the fusion pore greater than 6 nm in diameter, but it collapses without
progressing toward full dilation. However, in the presence of αS, more vesicles reach states of the
sustained large fusion pore. Our results suggest that membrane binding of αS is responsible for
the stimulating activity of fusion pore expansion.
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5.5 Materials and methods
5.5.1 Plasma Constructs and Site-Directed Mutagenesis
DNA sequences encoding SNAP-25 (amino acids 1-206), SNAP-25E (amino acids 1-180), syntaxin-
1A (amino acids 1-288), VAMP2 (1-116), αS (amino acids 1-140) including all mutations, and αS
1-95 (amino acids 1-95) are inserted into a pGEX-KG vector as N-terminal glutathione S-transferase
(GST) fusion proteins. Native cysteines are replaced by alanines for all the sequences. DNA se-
quences are confirmed by the Iowa State University DNA Sequencing Facility.
5.5.2 Protein Expression and Purification
N-terminal SNARE GST fusion proteins (SNAP-25, SNAP-25 E, syntaxin-1A, and VAMP2) are
expressed in Escherichia coli BL21 (DE3) competent cells. Cells are grown at 37◦C in LB medium
with ampicillin (100 µg/mL) until the absorbance at 600 nm reaches 0.6–0.8, and induced (through
addition of IPTG (isopropyl β-D-thiogalactopyranoside, 0.3 mM final concentration) to express
overnight at 16◦C. Cells are pelleted and resuspended in a wash solution (497 mM NaCl, 2.7 mM
KCl, 10 mM Na2HPO4 , 1.8 mM KH2PO4, pH 7.4, [4 g/L Triton-X 100 added for the membrane
proteins, VAMP2 and syntaxin-1A]) with final concentrations of 1 mM AEBSF [4-(2-aminoethyl)
benzenesulfonyl fluoride and 4 mM DTT (dithiothreitol). Cells are lysed by homogenization and
centrifuged to separate the supernatant from the pellet. The supernatant is collected and mixed
with reduced glutathione resin in a batch purification method. After incubation, the protein is
purified by washing the resin with wash solution. After washing, the resin is equilibrated into an
elution buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4, [0.8%
octyl-beta-glucoside (OG) added for the membrane proteins]). Proteins were eluted by cleavage
with 30 U of thrombin at 4◦C for 16 hours. The protein was stored at -80◦C with 15% glycerol.
αS (wild type, mutants, and truncated variants) are expressed and purified in the same manner
as detailed above, but have an additional step. The elution was further purified using FPLC
employing a custom poured size exclusion column packed with toyopearl HW-50F in a 2.5cm x
60cm Chromaflex column. PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4,
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pH 7.4) was used as the mobile phase. 5 mL fractions were collected and samples of each fraction
were run on a 15%-SDS-PAGE gel to identify fractions that lacked higher molecular weight species.
Pure fractions were combined, concentrated, and stored at -80◦C with 15% glycerol.
5.5.3 Membrane Synthesis
The lipids used to form the supported-bilayer (t-lipids) are made using a mixture of POPC (1-
palmitoyl-2-dioleoyl-sn-glycero-3-phosphatidylcholine), DOPS (1,2-dioleoyl-sn-glycero-3-phosphatidylserine),
PIP2 (phosphatidylinositol 4,5-bisphosphate), and PEG2000-PE
(1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000]) in chlo-
roform at a molar ratio of 78:15:2:5. The lipid mixture is first dried under an air stream, then dried
further in a vacuum overnight. The t-lipids are resuspended in HEPES-OG (25 mM HEPES/KOH,
150 mM KCl, 1% β-OG, pH 7.4).
The lipids used to form liposome for v-SNARE VAMP2 reconstitution (v-lipids) are made using
a mixture of POPC, DOPS, and cholesterol in chloroform at a molar ratio of 54:5:40. The v-lipids
are resuspended in HEPES with 90 µM Rhodamine B conjugated to 10 kD dextran (RB-dextran)
before 10 flash freeze-thaw cycles, moving between liquid nitrogen and boiling water. Unilamellar
vesicles were prepared by extrusion through 100 nm diameter polycarbonate filters to make v-
liposomes.
5.5.4 SNARE Reconstitution
For the supported bilayer, syntaxin-1A and SNAP-25 are premixed in a molar ratio of 1:1.5,
and the mixture incubated at room temperature to form the t-SNARE complex. The t-lipids are
added to the t-SNARE complex at a lipid:syntaxin-1A ratio of 2000:1. The mixture is diluted
3-fold using HEPES to reduce detergent concentration and insert the t-SNARE complex into the
t-lipids. The mixture is then dialyzed overnight at 4◦C in 2L of HEPES containing Bio-BeadsTM
SM-2 Resin to remove all detergent.
81
For content vesicles, v-liposomes are mixed with VAMP2 at a lipid-to-protein ratio of 200:1.
The mixture is diluted and dialyzed in the same manner as described above while ensuring that
concentration of RB-dextran constant at ∼90 µM.
5.5.5 Vesicle-to-Supported Bilayer Fusion Release Assay
A quartz slide and glass cover slip are cleaned and hydroxylated by boiling in a piranha solution
(1:1 mixture of concentrated sulfuric acid and 30% hydrogen peroxide) for 15 minutes. Afterwards,
the slide and cover slip are thoroughly rinsed with ddiH2O and placed in a cleaning sonicator for
30 minutes to remove residual acid. The slide and coverslip are then dried assembled to generate
several microfluidic chambers separated by double sided tape. The chambers are filled with t-bilayer
prepared from the overnight dialysis. The t-bilayer formed on the quartz surface for 2 h at 37◦C.
The excess liposomes/protein mixture was washed out with HEPES and replaced with 5 µM αS.
The microfluidic chambers are then placed on the imaging stand of our microscope. Imaging oil
was put on the prism of our prism-type total internal reflection fluorescence (TIRFM), and then
the prism was lowered onto the quartz slide. The incident angle of the exciting laser (532 nm) was
adjusted and we initiated real-time movie acquisition with an imaging area of ∼55 ∼110 µm using
20 ms time resolution. To perform fusion, we injected the v-vesicles from dialysis with 5 µM αS into
the microfluidic chamber at a rate of 50 µl/min. The sample to be injected into the flow cell has
250 nM of v-vesicles (total lipid concentration) encapsulating ∼90 µM of RB-dextran. The sample
contains 3.75 nM of RB-dextran in the bulk solution which does not affect our measurements.
We collected 60 second videos for each microfluidic chamber and analyzed fusion events using our
custom-built analysis software.
5.5.6 Data Analysis
Fluorescence of RB-dextran from the content vesicles is monitored to determine content release
from fusion events using in-house MATLABR 2019 (a) analysis software. Each recording is analyzed
frame by frame based on both visual determination and fluorescence trace pattern analysis.
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Large pore content release is indicated when a vesicle immobilized and fused on the surface
displays 2D diffusion of the fluorophore. The corresponding fluorescence trace shows a large spike
in fluorescence followed by a sharp decrease within less than 2 seconds. Events that did not form
a large pore are indicated when a vesicle immobilized on the bilayer with no visible 2D diffusion of
the fluorophore. The corresponding fluorescence trace shows a large spike in fluorescence followed
by a slow decay to baseline over several seconds. Non-release events are when a vesicle became
immobilized on the surface and disengaged after several seconds without any visible release. The
fluorescence trace of a non-release event contained a sharp increase in fluorescence, did not decay
over several seconds during a plateau period, and then sharply declined to baseline. Non-release
events were not included in the data analysis. This lack of fluorescence decay also indicates that
photobleaching is not observable in the time scales we are measuring.
The selected traces corresponding to large pore content release events are background corrected
by fitting the minimum baseline for all traces from a single recording with a polynomial and then
subtracting the polynomial from all the traces. The number of content release events are manually
counted. The duration of release was quantified as the time from the beginning to end of large pore
content release.
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Figure 5.1 Pathway of SNARE-mediated membrane fusion.
The v-SNARE VAMP2 located on the incoming vesicle initiates binding to the t-SNAREs
syntaxin-1A and SNAP-25 on the plasma membrane. The v-and t-SNAREs begin to zipper into a
coiled-coil that docks the vesicle to the plasma membrane. Continued zippering drives the outer
leaflets of the two membranes to merge into a hemifusion state. Complete zippering drives the
merger of the inner leaflets of two bilayers, which creates a small fusion pore. The small pore
expands to a large pore, resulting in complete merger of the vesicle to the plasma membrane. The
box shows the transition to which our single vesicle fusion assay is designed to be sensitive.
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Figure 5.2 Single vesicle-to-supported bilayer fusion assay to monitor a large fusion pore.
(a) Schematic of the content release assay. (b) Detection of large pore fusion event. Before the
injection of vesicles, there is a black background (grey trace). As vesicles are injected and dock to
the surface, there is a spike in the fluorescence intensity (red trace) visualized by a fluorescent
spot. After a short plateau (red trace), the vesicle develops a large fusion pore, where the
fluorescence intensity increases sharply and declines sharply thereafter (green trace). During this
period of increase and decline, the vesicle discharges content, which can be visualized by 2D
diffusion of fluorophores. As the large pore contracts in size, the internal content escapes slowly,
producing a slow decay (blue trace). This is visualized by a gradual dimming of the fluorescent
spot to the black background. (c) Hypothetical model of membrane deformation in vesicle fusion.
Here, SNARE complexes are not shown for clarity. (d)Controls for the SNARE dependence of the
large fusion pore. (e) Fluorescence trace of a non-release event. There is no decay in fluorescence
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Figure 5.3 SNAREs are inefficient at driving formation of the fusion pore larger than 6
nm.
(a) Representative fluorescence time-traces of SNARE mediated fusion. Docked vesicles without
apparent release (left) and with release (right) determined by 2D diffusion of fluorophores are
shown. (b) Distribution of the number of large pore events for individual docked vesicles. Total 4
independent measurements were analyzed for b-d. (c) Distribution of duration of the large fusion
pore, which is measured by the green part in Fig. 5.2B. (d) Distribution of the relative maximum
fluorescence intensity. Maximum intensities of individual events are normalized to the average
intensity at the moment of vesicle docking. (e) Representative time traces of the content release
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Figure 5.4 αS promotes probability, duration, but not the size of the large fusion pore.
(a) Distribution of number of large pore events for individual docked vesicles. For αS, events from
7 independent measurements were analyzed for a-c. (b) Distribution of the duration of the large
fusion pore. (c) Distribution of relative maximum intensities of large pore events. (d)
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Figure 5.5 The SNARE interaction with αS does not affect fusion pore expansion.
(a) Distribution of number of large pore events for individual docked vesicles. For αS 1-95, events
from 5 independent measurements were analyzed for a-b. (b) Distribution of the duration of the
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Figure 5.6 Membrane binding of αS plays a role in stimulating fusion pore expansion.
(a) Distribution of number of large pore events for individual docked vesicles. For αS A11P/V70P,
124 release events were detected out of 289 total events from 18 independent measurements. For
αS T44P/A89P, 98 large pore events were detected out of 209 total events from 19 independent
measurements. All the events were analyzed for a-c. (b) Distribution of the duration of the large
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Figure 5.7 Familial mutations A30P and A53T of αS moderately reduce the duration of
the large fusion pore.
(a) Distribution of docked vesicles vs. number of large pore events. In total for αS A30P, 288
large pore events were detected from 290 total events from 4 independent measurements. For αS
E46K, 326 large pore events were detected from 331 total events from 5 independent
measurements. For αS A53T, 322 large pore events were detected from 337 total events from 7
independent measurements. (b) Distribution of the duration of the large fusion pore. (c)
Distribution of relative maximum intensities of large pore events.
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CHAPTER 6. SUMMARY OF FINDINGS
6.1 Conclusion
SNARE-mediated membrane fusion has been a popular topic of study due to its fundamental role
in neurotransmission. Studies have elucidated the individual components of the SNARE complex
and its role as the minimal fusion machinery, however important, this information is only the
initial stages of an in-depth field of study. Neurotransmission is a complex multi-step process
that is regulated by a host of accessory proteins. Recent advancements in technology have made
it possible to investigate the role of each of these accessory proteins individually and asses their
specific mechanism of action on the membrane fusion pathway.
The SNARE complex is formed by zippering together the v- and t-SNARE components. This
is an extremely rapid process that provides the energy for membrane fusion. We hypothesized that
the accessory proteins would interact and help stabilize the v- and t-SNARE components prior to
zippering. For instance, Botulinum toxin A and E are neurotoxins that cleave 9 and 26 residues off
of the C-terminus of SNAP-25, respectively. Both neurotoxins have been shown to inhibit SNARE-
mediated membrane fusion, but the mechanism of action is unclear. Using EPR, we found that
the t-SNARE is initially dynamic, but when using BoNT A/E cleavage products the t-SNARE
is further destabilized. Using a single-molecule FRET vesicle-vesicle assay, it was observed that
BoNT A cleavage products were able to display lipid mixing, but the BoNT E cleavage products
were not. The BoNT A cleavage products were shown to be inhibitory to the content release. Thus,
the study was able to show that BoNT E inhibits vesicle docking, while BoNT A inhibits content
release.
One accessory protein of interest is α-synuclein. α-synuclein is popular for its pathological
aggregation into fibrils and Lewy Bodies, but its normal function is undefined. There are conflicting
studies that propose that α-synuclein may enhance SNARE-mediated membrane fusion, but others
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that say overexpression leads to inhibition. To sort this discrepancy, we used an in vitro single-
vesicle-to-supported bilayer merger assay employing TIRF. We found that α-synuclein is beneficial
for SNARE-dependent vesicle docking even at excessive concentrations, but the apparent toxicity
might be due to the presence of the aggregated species. Interestingly, α-synuclein was not shown to
impact the kinetics of membrane fusion. Furthermore with our study, we did not observe any vesicle
clustering with the concentrations we used. These findings defines a potential role of α-synuclein
in the membrane fusion pathway.
To further define the role of α-synuclein, we developed a vesicle-to-supported bilayer content
release assay. This assay is unique due to its ability to measure a large fusion pore through the use
of fluorescent probes conjugated to a 10 kDa dextran (∼6 nm). Pore expansion has been thought to
be the most energy dependent step in the membrane fusion pathway, and it has been proposed that
the membrane binding properties of α-synuclein might play a role in lowering that energy barrier.
We found that SNAREs alone are inefficient at formation of the fusion pore, but with the addition of
α-synuclein nearly all vesicles form a large fusion pore. Interestingly, α-synuclein increases both the
probability of forming a large pore and also increases the duration of the pore longer than SNAREs
alone. Truncation of the C-terminus of α synuclein (1-95) that removes the VAMP2 interacting
region displays the same activity as the wild-type indicating that the role in pore expansion is
independent of the SNARE-interaction region. Mutations on α-synuclein that decrease membrane
binding were shown to decrease the large pore duration directly in the rank order of the membrane
binding ability, thus confirming the role of membrane binding in pore stabilization.
The development of the single vesicle-to-supported bilayer fusion assay presents many new
opportunities for the study of membrane fusion pathway. Our studies with α-synuclein only scratch
the surface of the types of studies possible on investigating fusion pore expansion. It is a platform
that allows detailed investigation of accessory proteins and their regulatory influence on fusion pore
expansion. It is the hope that these findings will lead to a greater understanding of the mechanisms
of neurotransmission potentially opening new avenues of treatment of neurodegenerative diseases.
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16. Fasshauer, D., Eliason, W. K., Brünger, A. T. & Jahn, R. Identification of a minimal core of
the synaptic SNARE complex sufficient for reversible assembly and disassembly. Biochemistry
37, 10354–10362 (1998).
17. Stein, A., Weber, G., Wahl, M. C. & Jahn, R. Helical extension of the neuronal SNARE
complex into the membrane. Nature 460, 525–528 (2009).
18. Jahn, R. & Scheller, R. H. SNAREs - Engines for membrane fusion. Nat. Rev. Mol. Cell
Biol. 7, 631–643 (2006).
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